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SUMMARY 
Integration of Rous sarcoma virus DNA into its host genome 
was analyzed under conditions where secondary integration via 
virus spread was inhibited. This was accomplished by using the 
noninfectious pol ,env alpha variant of the Bryan high titer 
strain of Rous sarcoma virus (BH-RSV). Twelve independent BH-
RSV-transformed chicken embryo fibroblast clones were obtained 
and the provirus-cell junction fragments were mapped by res-
triction endonuclease cleavage and Southern blotting analyses. 
We found that expression of the viral genes could occur after 
proviral integration at many sites on the chicken genome and 
that there was no apparent preference for specific integration 
sites. 
BH-RSV DNA was further analyzed in order to precisely 
determine the defects in this strain. A 5 kb EcoRI fragment 
which contained the entire pol and src genes was molecularly 
cloned from integrated proviruses of BH-RSV alpha and its pol 
parent BH-RSV beta. 
DNA sequencing of the pol-src junction of BH-RSV revealed 
that the env sequence was almost entirely absent; only 6 bp 
following the pol stop codon remained. Starting at position 7 
(relative to the end of pol), a 91 bp sequence identical to the 
91 bp immediately upstream from src in other strains of Rous 
sarcoma virus (RSV) was found. This was followed by the src 
coding sequence. It appears remarkable that in all RSV 
strains, including this defective BH-RSV, as well as in 
vii 
cellular-src DNA, these 91 bp are conserved. 
The helper virus-related sequence of about 100 bp, which 
is present as a direct repeat in the 5' and 3' sides of src in 
other RSVs, was present only on the 3' side of src in BH-RSV. 
The sequence of about 100 nucleotides immediately following src 
in BH-, PR-, and SR-RSV seems to be completely unconserved. 
Restriction enzyme mapping analysis showed the structure 
of the BH-RSV alpha pol gene to be basically unchanged from 
that of BH-RSV beta. Using cloned DNAs, we have constructeds 
molecular clones in which the pol gene of non-defective RSV was 
replaced with the pol gene of BH-RSV alpha or BH-RSV beta. The 
BH-RSV alpha pol gene was found to be biologically inactive in 
a transfection assay. Further in vitro recombination localized 
the lesion to an 859 bp Xbal-Bglll fragment in the second third 
of the pol gene. 
Analysis of the proteins synthesized in BH-RSV alpha-
infected cells revealed the fact that BH-RSV alpha directed the 
synthesis of a full-sized Prl80 gag-pol precursor, yet no po-
lymerase related proteins were found in BH-RSV alpha virion 
particles. The pol lesion in the BH-RSV alpha genome appears 
to cause a defect in the processing or packaging of reverse 
transcriptase. 
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A Note on Nomenclature: This thesis presents studies on two 
isolates of BH-RSV: BH-RSV alpha (genotype gag ,pol ,env ,src ) 
and BH-RSV beta (genotype gag ,pol ,env ,src ). In the text, 
the term "BH-RSV" was used in a general sense to refer to both 
BH-RSV alpha and beta. The terms "BH-RSV alpha" and "BH-RSV 
beta" were used to refer to a specific isolate. 
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INTRODUCTION 
Classification. Avian RNA tumor viruses are classified in the 
family Retrovirdae, subfamily Oncovirinae [91]. Retroviridae, 
or retroviruses, are positive strand RNA viruses which contain 
an RNA-dependent DNA polymerase (reverse transcriptase, E.C. 
2.7.7.7) and replicate via a DNA intermediate. Avian RNA tumor 
viruses (also known as avian sarcoma and leukemia viruses) can 
be further classified into two groups, slowly transforming 
viruses and rapidly transforming viruses, on the basis of both 
pathology and genetics. 
Slowly transforming viruses are replication competent 
viruses that may cause neoplastic disease in vivo after a rela-
tively long latent period and generally do not affect the mor-
phology of cells in tissue culture. These viruses do not con-
tain genes other than those needed for replication. Rapidly 
transforming viruses are usually defective for replication but 
cause rapid neoplastic disease in vivo and morphological 
transformation of cells in tissue culture. Rapidly transform-
ing viruses contain a specific gene which is responsible for 
their oncogenic and transforming abilities. The tranforming 
genes, generically known as one genes, are highly related to 
normal cellular genes (c-onc genes). Rapidly transforming 
viruses are believed to have arisen via recombination events 
between slowly transforming viruses and c-onc genes. 
Virus Particle. Retroviruses possess an enveloped particle 
which is released from host cells by the process of budding. 
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The physical particle (virion) of avian retroviruses consists 
of: i) an internal core of viral structural proteins, pl9, plO, 
p27, pl2, and pl5, ii) an outer membrane derived from the host 
plasma membrane, and iii) viral surface glycoproteins embedded 
within the outer membrane, gp85 and gp37. Two chemically and 
genetically identical subunits of RNA and 10-20 molecules of 
reverse transcriptase are packaged within the viral core. Each 
RNA subunit is a complete viral genome, 8-10 kb (34-39S sedi-
mentation value) in non-defective viruses. The RNA is single 
stranded, capped at its 5' end, and polyadenylated on its 3' 
end. The two genomic RNA molecules are hydrogen bonded at or 
near their 5' ends, forming a 60-70S viral RNA complex. Also 
within the core, is a selected population of cellular tRNAs and 
trp 
low molecular weight ribosomal RNAs, including tRNA c, the 
primer for negative strand viral DNA synthesis. 
Life Cycle. Virus can be adsorbed non-specifically to the 
host's cell surface; however, penetration requires a specific 
interaction between the viral glycoprotein and receptors on the 
host cell membrane. Penetration will not occur if the virus 
lacks surface glycoproteins or if the cells lack the proper re-
ceptors. Once inside the cell, the virus uncoats by an unknown 
mechanism and viral RNA is reverse transcribed in the cyto-
plasm. Double stranded viral DNA is transported to the nucleus 
and integrates into the host cell DNA. Integrated viral DNA 
(provirus) then behaves like a stable Mendelian gene. 
The provirus serves as the template for viral RNA syn-
thesis. Transcription of viral RNA is controlled by a viral 
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promoter mapped to the U~ region [66,152], which is located on 
the 5' end of the provirus (see below). Host nucleic acid and 
protein synthesis are not turned off as a result of the activi-
ty of the virus; the provirus is essentialy a subset of the 
host's actively transcribed genes. Viral mRNAs consist of both 
genomic-sized RNA and sub-genomic sized RNA species, the latter 
generated by splicing. 
Viral proteins are assembled at the cell membrane. Virion 
cores containing reverse transcriptase and viral RNA (indistin-
guishable from genomic-sized mRNA) bud through the cell mem-
brane into the extracellular medium. The host cell is usually 
not killed as a result of viral infection, and once infected, 
the cell continues to release viral particles throughout its 
lifespan. Viral genetic information is thus transmitted both 
by infection of new cells (horizontal transmission) and by cell 
division of infected cells (vertical transmission). 
Reverse Transcription and Integration. Viral DNA differs from 
its RNA template in that it contains a long terminal repeated 
sequence (LTR) at both ends. LTRs are composed of sequences 
which derive from 1) the 3' end of viral RNA (U3), 2) from a 
short direct repeat found at both ends of viral RNA (R), and 3) 
from the 5' end of viral RNA (UJ. The order of these se-
quences is U--R-Ur and, in the avian system, the approximate 
size of these regions is 250, 20, and 80 bp respectively. Gen-
eration of a terminal repeat derived from both ends of viral 
RNA implies that the process of reverse transcription is more 
complex than merely copying a viral template. 
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Reverse transcriptase requires a primer to initiate DNA 
synthesis. In avian retroviruses this is supplied as a 
molecule of tRNA p which is base-paired at its 3' terminus to 
a stretch of viral RNA (16 bp) located immediately following 
Ur. Synthesis of DNA complementary to viral RNA (minus strand 
DNA) utilizes the 3' OH of the tRNA as a primer and proceeds in 
a 5' to 3' direction (i.e., opposite direction with respect to 
viral RNA) for 101 bp ("minus strong stop DNA"), until the 5' 
terminus of viral RNA is reached. The nascent DNA transcript 
then "jumps" and hybridizes to an R sequence on the 3' end of 
another viral RNA molecule. Synthesis of minus strand DNA con-
tinues in a continuous fashion up to the primer binding site. 
The minus strand DNA is thus a complementary copy of VIRAL 
GEN0ME-U3-R-U5. 
The primer for plus strand synthesis has not been identi-
fied, but is presumed to bind to a highly conserved polypurine 
tract (PPT) which immediately precedes U~. Plus strand syn-
thesis appears to initiate before completion of the minus 
strand. Initiation at the proposed primer binding site and 
synthesis in the 5' to 3' direction (i.e., same direction as 
viral RNA) would generate a DNA transcript of U^-R-Uj. ("plus 
strong stop DNA"). Continued reverse transcription of the 3' 
end of tRNA ^ would generate a region complementary to the 3' 
end of minus strand DNA (5' end of genomic RNA) and would fa-
cilitate a second jump to a new template molecule or circulari-
zation of the growing minus and plus strands. The minus strand 
acquires its second U--R-U,- by transcription of "plus strong 
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stop DNA". The plus strand acquires VIRAL GEN0ME-U3-R-U5 by 
transcription of minus strand DNA. The final product is double 
stranded DNA with two copies of U3~R-U5 (the LTR). 
This model has been proposed by Gilboa et al. [37]; simi-
lar models have been proposed by others [28,67]. Experimental 
evidence in support of the model was obtained by exploiting the 
ability of actinomycin D to specifically inhibit DNA-dependent 
DNA synthesis, thus enabling investigators to distinguish 
between plus and minus DNA transcripts. The existence of minus 
"strong stop DNA" has been well documented; recently "plus 
strong stop DNA" has been identified as a reverse transcription 
intermediate in many retrovirus systems [10,28,79,93]. Reverse 
transcription of the 3' end of the tRNA primer by the nascent 
plus strand has been shown in some avian and murine rerto-
viruses [37,132,137]. There is still some uncertainty as to 
whether the plus strand is synthesized as one continuous strand 
[37] or whether a strand displacement mechanism is involved 
[67]. 
Integration is highly specific with respect to the viral 
genome. The structure of the provirus is CELL DNA-U_-R-Ue-
VIRAL GENOME-U3-R-U5-CELL DNA. However, integration apparently 
occurs randomly with respect to the host genome (see chapter 
1). The process of integration causes a 4-6 bp duplication of 
host sequences at the site of integration 
[27,56,63,86,121,124], a property retroviruses share with 
prokaryotic and eukaryotic transposable elements. 
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Figure 1̂ . Genetic structure and protein products of non-
defective avian retroviruses. The structure shown is that of 
an RSV provirus; except for the src gene, the remainder of the 
genome is the same in ALV. The primary translation products of 
viral mRNAs and their mature cleavage products are shown 
beneath the DNA sequences which code for them. Recently, a 
fifth gag protein, plO, has been mapped to the region between 
pl9 and p27 [103]. 
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Slowly Transforming Viruses: 
Genetic Structure. The prototype slowly transforming 
viruses are the avian and murine leukosis viruses (ALV and 
MuLV). ALVs include Rous associated viruses (RAV) and related 
viruses. RAV-1 and RAV-2, commonly used laboratory strains, 
were originally isolated as replication competent "helper" 
viruses in defective Rous sarcoma virus (RSV) stocks [41,109]. 
These viruses contain 3 genes whose products are both necessary 
and sufficient for viral replication: gag, pol, and env (Fig. 
1). 
The gene order, gag-pol-env seems to be invariant. The 
LTR (U3-R-U,-) is present on both ends of the proviruses. In 
addition to the three coding regions, there are non-coding se-
quences upstream from gag and downstream from env. 
Studies of the DNA of normal uninfected chickens demon-
strated the existence of at least 16 genetic loci (numbered 
ev-1 to ev-16) containing endogenous viral sequences, structur-
ally related to ALV. Most chickens of the White Leghorn breed 
(which is commonly used in laboratory studies) seem to contain 
at least the ev-1 locus; usually one to three additional ev's 
are also present. Most ev's have multiple defects and are thus 
unexpressed; some ev's express part of gag ("gs " phenotype) 
and/or env ( "chf " phenotype) [53]. 
Transcription and Translation: The gag gene codes for the 
viral structural proteins, pl9, plO, p27, pl2, and pl5. 
Genomic-sized mRNA is translated into a 76 kD gag polyprotein 
precursor product (Pr76^ "), which undergoes proteolytic 
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cleavage to generate the five viral proteins. Processing oc-
curs in the infected cells and pulse-chase experiments have 
demonstrated a presursor-product relationship between Pr76 and 
the mature gag proteins [51,100]. 
The pol gene codes for reverse transcriptase. In the avi-
an system the active enzyme is a dimer consisting of one 
molecule of an alpha subunit, p63p , and one molecule of a 
beta subunit, p95po . p95 occupies most, if not all, of the 
pol coding sequences [117], and p63 is an amino terminal 
cleavage product of p95 [34]. The carboxy terminal cleavage 
product of p95 is a 32 kD phosphoprotein (pp32, or p32) which 
has DNA endonuclease activity [115]. The exact role of the p32 
endonuclease in replication has not been determined. 
The identity of the mRNA species used for translation of 
pol remains an enigma. The primary translation product of pol 
is a 180 kD polyprotein precursor shown to have gag and pol an-
tigenic determinants and to contain the tryptic peptides of 
Pr76gag and p95po1 [100,105]. Prl80, however, is not a pre-
cursor to Pr76 since radioactivity from Prl80 does not "chase" 
into Pr76 and since there is 20-50 times more Pr76 than Prl80 
in cells even at early time points [100]. Prl80 was therefore 
considered to be a read-through protein resulting from occa-
sional suppression of the gag termination codon used in syn-
thesis of Pr76. However, in vitro translation in the presence 
of tRNA amber suppressor molecules yielded an 80 kD protein at 
the expense of Pr76 and did not result in an increase in Prl80 
[147]. Recent DNA sequencing revealed the surprising fact that 
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gag and pol were encoded on different reading frames on viral 
DNA. The most plausable explanation for the synthesis of Prl80 
requires that a splicing event removes the gag termination co-
don and 10 to 20 bp in the vicinity of the gag-pol juncton, 
resulting in a shift to the -1 reading frame while avoiding 
creation of new in-frame termination codons. The presence of a 
spliced pol mRNA has yet to be demonstrated. If such a 
molecule exists, a percentage of virion particles may contain 
this RNA instead of genomic RNA since in vitro translation of 
virion RNA resulted in the synthesis of Prl80 and Pr76 in prac-
tically the same ratio as found in infected cells [147]. 
The precursor-product relationship between Prl80 and 
p95/p63 has been inferred from pulse-chase experiments in which 
the kinetics of disappearance of Prl80 from infected cells 
correlates extremely well with the kinetics of appearance of 
p95 and p63 in virion particles [100]. Since p95 and p63 do 
not appear in immunoprecipitates of infected cells and since 
Prl80 has not been convincingly shown to be present in virion 
particles, it was not possible to demonstrate a direct rela-
tionship. Preliminary evidence presented in this thesis indi-
cates that it may be possible to demonstrate a direct 
precursor-product relationship in the virion particles. 
The env gene codes for the viral glycoproteins, gp85 and 
gp37. A 21S subgenomic spliced mRNA is translated into a 
env 
glycosylated precursor, gPr92 , the major viral glycoprotein 
detected in infected cells. In the presence of inhibitors of 
glycosylation, this precursor runs as a 57 kD unglycosylated 
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protein. The product of cell-free translation of 21S mRNA runs 
as a 63 kD unglycosylated protein, presumably due to the pres-
ence of a signal peptide in the in vitro synthesized product. 
Cleavage of gPr92 to gp85 and gp37 and formation of disulfide 
linkages between the two env proteins occurs near the time of 
budding, although the exact sequence of events is not clear. 
gp85 confers subgroup specificity upon the virion par-
ticle. There are 6 defined viral subgroups, designated A-F, 
which are encoded in different viral gp85 genes. Since host 
cells may contain receptors on their surfaces for only some of 
these 6 subgroups, host range is also related to gp85. Because 
of variations in subgroup, the gp85 portion of env is the part 
of the genome that displays the most variability among various 
viral strains. 
The leader sequence of the spliced env mRNA contains ap-
proximately 250 nucleotides from the 5' end of the genome. The 
proposed splice donor site is located at nucleotide 18 of the 
Pr76 coding sequence; the proposed splice acceptor site for env 
is found within the coding sequences for an env signal peptide. 
This implies that the signal peptide is composed of amino acids 
which are partially derived from the leader sequence (i.e., the 
first 6 amino acids). Interestingly, DNA sequencing has shown 
that the coding sequences of pol and the env signal peptide 
overlap by ~110 nucleotides with pol and env in different read-
ing frames. The actual coding sequences do not overlap; env 
begins 56 bp after pol terminates. 
Rapidly Transforming Viruses: 
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Rous Sarcoma Virus. Rapidly transforming viruses are 
characterized by the presence of a specific one sequence in-
serted into their genomes in addition to, or instead of, the 
replicative genes. The most extensively studied virus of this 
class has been RSV (Figure 1). 
In RSV, gag, pol and env are present and are transcribed 
and translated in the same manner as described for ALV. The 
size of the env mRNA of RSV is 28S, since both env and src are 
transcribed; however only env is translated from this mRNA. 
In addition to the ALV genes, RSV has a sequence known as 
src inserted into its 3' end, between env and the LTR. On-
cogenicity and transformation in tissue culture can be directly 
attributed src since 1) ALV and RSV, which have quite different 
pathologies, are essentially identical except for this se-
quence, and 2) spontaneously-derived deletion mutants in src 
are invariably transformation defective (td) and have lost the 
ability to cause rapidly appearing tumors in vivo [70]. The 
isolation of mutants which were temperature sensitive for 
transformation [72,89] suggested that the src gene product was 
a protein. Finally, Erikson et al identified a 60K product of 
the src gene which had an associated protein kinase activity 
[35,36]. 
Unlike the other viral proteins, src is not a cleavage 
product of a larger protein precursor. p60 is the primary 
translation product of a separate spliced subgenomic mRNA of 
21S. 
Other Rapidly Transforming Viruses. Based on the genetic 
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structure of RSV, the prototype transforming virus was con-
sidered to be composed of gag-pol-env-one; transforming viruses 
which were replication defective (i.e., lacked gag, pol and/or 
env information) were considered to be exceptions to this rule. 
The first defective transforming virus to be described was 
the env-defective Bryan high titer strain of RSV (BH-RSV) [45]. 
It has subsequently become clear that, except for certain 
strains of RSV, all rapidly transforming viruses are defective 
in replication. One or more replicative genes are replaced by 
a new sequence containing the one gene. Cells containing such 
viral genomes are transformed but do not release infectious 
viral particles ("non-producer" cells). Figure 2 compares the 
structures of some rapidly transforming viruses with that of 
ALV. 
The structures of the defective viruses range from re-
placement of one gene (BH-RSV and AMV) to replacement of all 
replicative genes (Ha-MSV). In viruses in which the one gene 
is inserted into gag, the transforming gene product is ex-
pressed as a gag-one fusion protein which is synthesized from a 
genome-size mRNA. Products of transfoming genes in more distal 
positions (such as AMV myb and AEV erbB) are thought to be syn-
thesized off subgenomic spliced mRNA transcripts. The src gene 
product of BH-RSV is known to be synthesized off a 21S mRNA 
similar to non-defective RSV. 
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Figure 2. Genetic maps of some representative viruses. In-
serted sequences, apparently of cellular origin, are shown in 
boxes. Sequences which code for transforming functions (indi-
cated by cross-hatching) are labeled according to the currently 
accepted nomenclature [17]. (In AEV the region identified as 
erb has recently been renamed erbA and the region identified by 
the question mark has been named erbB.) 
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In order to replicate, defective transforming viruses re-
quire that the missing viral products be supplied by a replica-
tion competent helper virus (such as ALV). The resulting 
virion particle is called a pseudotype; the physical particle 
is derived partly or wholly from the helper virus and the RNA 
genome is from the defective virus. 
Origin of the one Sequences. Stehlin et al. discovered that 
cDNA specific for src hybridized to cellular DNA of normal 
uninfected chickens with kinetics which indicated that one to 
two copies of a cellular src (c-src) gene were present [130]. 
Hanafusa et al. found that upon injection of partial td mutants 
of RSV into chicks, tumors arose after a long latent period 
from which a non-defective RSV could be recovered [43]. Stu-
dies of the RNAse T, oligonucleotide fingerprints [146] as well 
as tryptic peptide analyses [68] revealed that the src genes of 
these recovered avian sarcoma viruses (rASV) were the products 
of recombination between the residual src of the partial td mu-
tant and the c-src gene. 
Subsequently, at least 13 more unique sequences, all of 
which have cellular homologs, have been identified as the 
transforming genes in different rapidly transforming retro-
viruses. These findings led to the, now generally accepted, 
hypothesis that transforming retroviruses arose by recombina-
tion events between helper viruses and c-onc genes. The level 
of expression and/or the structure of the c-onc genes seem to 
have been altered as a result of this recombination, endowing 
these normal genes with potent transforming abilities. 
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Early History of RSV; Origin of the Common Laboratory Strains. 
In 1911 Peyton Rous of the Rockefeller Institute reported the 
isolation of a filterable agent which produced sarcomas in 
chickens [107]. The filtrate originated from a spontaneous tu-
mor in a Plymouth Rock hen; it was designated "Chicken tumor 
#1" by Rous, and later became known as Rous sarcoma virus. The 
tumor had been passaged for a few years by transplantation in 
blood relatives of the original chicken before it acquired the 
ability to grow in all breeds of chickens. After the discovery 
of the "filterable agent", virus was routinely passaged by ino-
culation into chickens and recovery from the resulting tumors. 
The virus was passaged by Rous and his collaborators in 
New York and samples were given to researchers at other insti-
tutions. However, the passage history of the virus was not 
well documented. RSV strains available today are all con-
sidered to be derived from the original RSV, but precise data 
on the evolution of each strain is not available. Until the 
1960s, when tissue culture methods became popular, RSV was pro-
pagated by in vivo passage. Since it is now known that in vivo 
passage can lead to the generation of novel recombinants 
[1,43,49], the relationship between the modern RSV strains and 
the original isolate is not clear. Unfortunately, there are no 
remaining samples of the tumor material isolated by Rous. 
Most research in the past twenty years has been performed 
on a few strains, named after researchers involved in their 
propagation. 1) The Schmidt-Ruppin strain of RSV (SR-RSV) was 
used extensively by K.H. Schmidt-Ruppin of Germany in the 
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1950s. His material originated from Rous' tumor; however it 
was passaged in two other laboratories before he received it in 
1953 [95]. 2) The Prague strain of RSV (PR-RSV) was used by J. 
Svoboda of the Institute of Biology in Prague in the late 
1950s. The genealogy of this strain is not clear. 3) The 
Bryan high titer strain of RSV (BH-RSV) was developed by W.R. 
Bryan of the National Cancer Institute in 1959 as a result of 
over 50 successive passages of virus in New Hampshire Red 
chickens. At each passage Bryan selected for the most rapidly 
growing tumor to use as material for the next round of inocula-
tion [14]. Bryan originally received RSV in 1941 from A. 
Claude of the Rockefeller Institute; Claude received it from J. 
Murphy, a collaborator of Rous [95]. 4) The Bratislavia 77 
strain (B77) of avian sarcoma virus was isolated as a spontane-
ous field isolate [141]. The original B77 stock may have been 
lost to contamination or mislabeling, since the present day 
"B77" is indistinguishable from PR-RSV. 
The Bryan Strain of Rous Sarcoma Virus. Hanafusa et al. showed 
that BH-RSV was defective in the production of infectious virus 
and required a helper virus for replication [41,45]. The de-
fect could also be overcome by passaging the virus in cells of 
certain chicken embryos. These embryos produced a "chicken 
helper factor" (chf) which rendered the BH-RSV virions infec-
tious for one round of replication on quail but not chicken 
cells. (It was later shown that chf was subgroup E viral 
glycoprotein; quail cells have receptors for this subgroup, 
whereas chicken cells generally do not). 
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Biochemical studies showed that BH-RSV virions lacked the 
viral glycoproteins, gp85 and gp37 [114]. Oligonucleotide map-
ping detected the presence of a large deletion in BH-RSV as 
compared to non-defective RSV [30]; the position of this dele-
tion thus defined the location of env on the genetic map. BH-
RSV was used extensively as the prototype env mutant to eluci-
date the function of the env gene products, to identify the env 
mRNA species, and to use as a negative selection for the 
preparation of env-specific DNA probes. However, the precise 
extent of the env deletion had not been determined and it was 
not known whether any residual env information was present in 
BH-RSV. 
Hanafusa et al observed that 5-10% of viral particles in 
BH-RSV stocks could not be complemented by passaging through 
chf cells [46]. These particles, termed BH-RSV alpha, were 
found to have an additional defect: reverse transcriptase ac-
tivity could not be detected in these virions [44,47,101,148], 
The pol defect was extremely stable; reversion of the pol 
phenotype to pol was not observed. However, upon superinfec-
tion of BH-RSV alpha-infected cells with helper virus, recombi-
nation occurred, resulting in the formation of the parental 
pol"*" BH-RSV (BH-RSV beta) . BH-RSV alpha is also capable of 
recombining with a pol mutant, tsLA337, to yield pol BH-RSV 
beta, but incapable of recombining with another pol mutant, 
tsNY21 [111]. This would suggest that the defect, most likely 
a deletion, maps to a particular region of pol. RNA sizing 
studies failed to detect a difference between BH-RSV alpha and 
-18-
the parental, BH-RSV beta [L-H Wang, personal communication]. 
The nature of this defect and the mechanism for its generation 
remained a puzzle. 
Since BH-RSV alpha virion particles contain viral RNA, 
selection of genomic RNAs for packaging into virions does not 
seem to require functional reverse transcriptase. However, 
BH-RSV alpha virions (as well as those of another pol mutant) 
do not contain significant amounts of tRNA ^ and the other 
small RNAs found avian retrovirus particles [104,113], thus im-
plicating the reverse transcriptase protein in selection of 
tRNAs for packaging. 
Scope of This Thesis: Because of their specific non-
conditional defects, the BH-RSV strains have traditionally been 
excellent model systems for studying many viral functions. In 
this thesis I present results of experiments using BH-RSV alpha 
to study the specificity of RSV integration into its host's 
DNA. Spread of infectious virus and concomitant multiple in-
tegration events occurred when non-defective RSV was used; this 
prevented examination of specific proviruses and the adjacent 
cellular DNA. With BH-RSV alpha as the exogenous virus, bands 
representing the single integrated provirus were readily 
detected and the lack of specific integration sites was clearly 
determined. 
I examined the structure and properties of the BH-RSV al-
pha and beta mutants in an attempt to fully characterize their 
defects. A DNA fragment containing the region flanking the env 
deletion in BH-RSV was sequenced, the nature of the pol protein 
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products encoded by BH-RSV alpha was determined, and the BH-RSV 
alpha defect was localized to a specific region of the pol 
gene. Based on sequence comparisons between BH-RSV and other 
retroviruses, I also obtained suggestive evidence for the im-
portance of specific non-coding regions flanking the src gene 
of RSVs. 
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MATERIALS AND METHODS 
Cells and Viruses: 
A clone of 3Y-1 rat cells infected with BH-RSV was ob-
tained from S. Kawai and grown in MEM media as described [69]. 
A stock of a RAV-1 pseudotype of BH-RSV alpha virus, [BH-RSV 
alpha (RAV-1)], was generously provided by T. Hanafusa. All 
preparations of BH-RSV alpha (RAV-1) are known to contain a 
small percentage of the pol BH-RSV beta (RAV-1) which is con-
sidered to be a consequence of recombination events which oc-
curred after superinfection with helper virus [46]. BH-RSV 
alpha-transformed chicken cells were grown in Scherer's or 
Hams' F-10 medium as previously described [42]. CEF were from 
gs , chf SPAFAS embryos. 
Viral Assays: 
The presence of infectious transforming virus was assayed 
by ability to form infectious centers on uninfected CEF in a 
standard hard agar focus assay [140]. Viral reverse transcrip-
tase activity on an exogenous template (poly rC:oligo dG) was 
measured under standard conditions [145]. 
Cloning BH-RSV Infected "Non-Producer" Chicken Cells: 
Clonal populations of chicken cells harboring BH-RSV pro-
viruses were obtained by infecting CEF with BH-RSV alpha (RAV-
1) at high virus dilutions (m.o.i. 10 -10 focus forming 
units/cell). Within 24 hours post-infection cells were over-
laid with agar medium containing antibody that neutralized 
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RAV-1. Individual foci picked on day 8 were cultured separate-
ly, and were continuously monitored for morphology, infectivi-
ty, and virion polymerase activity. Clones of cells that were 
morphologically transformed, but did not produce infectious 
virus as assayed by focus formation, were further monitored for 
the production of virus particles by sucrose gradient banding 
35 
of [ S]-methionine labeled particles from labeled cultures 
[106]. Transformed clones producing noninfectious virions were 
designated as BH-RSV clones. Those BH-RSV clones which, in ad-
dition, released polymerase-negative particles were designated 
BH-RSV alpha clones; the clones in which sedimentable polym-
erase activity was detected were designated BH-RSV beta clones. 
[BH-RSV beta clones have also been referred to in previous stu-
dies as BH-RSV(-)]. 
DNA Extraction: 
g 
DNA was extracted from pellets of 10 cells by the pro-
cedure of R. Junghans, Roche Institute (personal communica-
tion) . The cell pack was lysed in extraction buffer containing 
70% guanidine thiocyanate, 10% 2-mercaptoethanol, 0.02 M Tris 
(pH 8), and 0.001 M EDTA. CsCl crystals were added to a final 
concentration of 1.4 g/ml and the final volume was adjusted to 
2 ml with extraction buffer. The lysate was layered on top of 
a preformed CsCl step gradient: 1.8 g/ml and 1.6 g/ml CsCl 
solutions in TEN buffer (0.01 M Tris (pH 7.4), 0.001 M EDTA, 
and 0.01 M NaCl). DNA was banded for 72 h at 34K in a fixed 
angle rotor (Beckman T40 or Ti50) and the DNA-containing frac-
tions, identified by viscosity and/or agarose gel electro-
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phoresis with ethidium bromide staining, were dialyzed against 
TEN buffer for a minimum of 5 buffer changes (at least 8 h per 
buffer change). Dialyzed DNA was then used directly in res-
triction enzyme reactions. 
Enzymes and Enzyme Reactions: 
Restriction endonuclease reaction conditions were as per 
manufacturer's (New England Biolabs or Bethesda Research La-
boratories) directions; enzyme buffers were either as recom-
mended by the manufacturer or as described in Davis, et al. 
[25]. Usually, at least a twofold excess over the recommended 
amounts of enzyme was used for digestion of chromosomal or 
closed circular plasmid DNA. 
Digestions of chromosomal DNA were monitored by incubation 
of an aliquot (usually 5%) of the chromosomal reaction mixture 
with 1 ug of lambda or Ad-2 DNA. This marker DNA was subjected 
to electrophoresis on an agarose gel, stained with ethidium 
bromide, and examined under UV light for completeness of diges-
tion. Chromosomal samples were precipitated in ethanol and run 
on agarose gels only after completeness of digestion was demon-
strated. Digestions of phage or plasmid DNA were monitored 
directly on agarose gels. 
Nick translation was performed as described by Maniatis, 
32 
et al. [88]. The labeled nucleotide was [alpha P]-dCTP, 
(specific activity: >2000 Ci/mmole) 10 mCi/ml in aqueous solu-
tion (Amersham) and DNA polymerase I was obtained from 
Q 
Boehringer-Mannheim; specific activities of 10 cpm/ug DNA were 
routinely obtained. 
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Ligation of DNAs was performed using under conditions 
recommended by the manufacturer for joining fragments with 
cohesive ends. Reactions contained 1 ul (10 units) of T. DNA 
ligase (New England Nuclear) in the recommended buffer (50 mM 
Tris (pH 7.4), 10 mM MgCl2, 50 ug/ml BSA, 1 mM ATP, 10 mM DTT) 
and were performed at 16 C for 3-12 hours. Ligation of lambda 
arms to insert DNA required a high DNA concentration in the 
reaction mixture (>100 ug/ml); ligation of plasmid and insert 
fragments to form circular products required more dilute DNA 
concentrations (10-50 ug/ml). 
Removal of 5' phosphate from DNA fragments was accom-
plished by bacterial alkaline phosphatase (Bethesda Research 
Laboratories) treatment at 68°C for 1 hr in 10-50mM Tris-HCl 
(pH 8.0). 
5' end-labeling of DNA fragments with T. polynucleotide 
kinase was performed at 37 C for 30 min. Reaction volumes were 
40 ul and contained between 0.5 and 10 pmoles of available 5' 
32 
ends and 40 pmoles of [gamma- P ]-ATP (Amersham, specific ac-
tivity 2000-3000 Ci/mmole, 10 mCi/ml in aqueous solution) in 
kinase buffer (50 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 5 mM DTT, 
0.1 mM spermidine, 0.1 mM EDTA). 
Gel Electrophoresis of DNA and Filter Hybridization: 
For agarose gel electrophoresis, DNA samples were run on 
submerged horizontal gels (20 x 25 x 0.5 cm or 8.5 x 5.5 x 0.5 
cm "mini-gels") in electrophoresis buffer (E buffer) (0.04 M 
Tris-acetate (pH 7.8), 0.005 M Na-acetate, and 0.001 M EDTA). 
The agarose concentration was usually 0.6-0.8% and size markers 
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were lambda HindIII fragments; however when small (less than 1 
kb) DNA fragments were examined, agarose concentrations of 
1.5-2% and size markers of pBR322 Hinfl fragments were used. 
DNA was visualized by ethidium bromide (0.5 ug/ml) staining and 
UV light excitation. 
For sizing restriction fragments smaller than 1 kb or as a 
preparative step in obtaining a labeled DNA fragment for 
sequencing, electrophoresis on polyacrylamide slab gels was 
performed. The concentration of polyacrylamide was 5 or 8% 
(the ratio of acrylamide to bisacrylamide was usually 19:1, 
although in some cases 50:1 ratios were used) in TBE buffer (50 
mM Tris (PH8.3), 50 mM boric acid, 1 mM Na EDTA) as described 
by Maxam and and Gilbert [92]. For both agarose and po-
lyacrylamide gel electrophoresis, the voltage and the time of 
electrophoresis was usually determined empirically. 
Southern transfer [127] of DNA from agarose gels to nitro-
cellulose filters (Schleicher & Schuell), hybridization to ra-
dioactive probes, and washing of filters were carried out as 
previously described [10, see also Molecular Cloning section 
below], except that unlabeled salmon sperm carrier DNA was ad-
ded to the hybridization solution at a concentration of 250 
ug/ml. Filters which were to be re-hybridized to a second ra-
dioactive probe were soaked in pre-hybridization solution (hy-
bridization solution with H20 substituted for formamide) at 
80 C for 10 min to remove the first probe. 
Radioactive Probes: 
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1. RAV-2 probe: RAV-2 DNA purified from a lambda RAV-2 
clone [65] was cut into two fragments with the enzymes Hindlll 
and Sail. Such cleavage generates one fragment of 4.25 kb, 
which contains a portion of the env gene, the LTR, and the en-
tire gag gene, and another fragment of 3.3 kb, which contains 
the entire pol gene and part of the env gene. These two frag-
ments have been subcloned separately into pBR322 [133]. 
32 
[ P]-RAV-2 probe was prepared by nick translation of a 1:1 
mixture of these two pBR322 subclones. 
32 
2. pol probe: [ P]-pol probe was prepared by nick translation 
of the pBR322 subclone containing the 3.3 kb Hindlll-Sall RAV-2 
fragment mentioned above. 
32 
3. cDNAc, : [ P]-cDNAc, which consists of the first 101 nu-
cleotides from the 5' end of RAV-2 (formerly known as "strong 
stop" DNA), was generously provided by B. Neel, The Rockefeller 
University. This probe was made by previously published pro-
cedures [50,53]. 
32 
4. LTR probe: [ P]-LTR DNA which contains all the 5' and 3' 
sequences present in one copy of the long terminal repeat of 
SR-RSV was obtained by EcoRI digestion of a lambda SR-RSV clone 
which contains two copies of the LTR [133] followed by nick-
translation of the purified 350 nucleotide'fragment. 
32 
5. src probe: [ P ]-src probe was made either by nick transla-
tion of a pBR322 subclone containing the 3.8 kb EcoRI src-
containing restriction fragment from the lambda SR-RSV clone 
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mentioned above [133], or by nick-translation of a purified 600 
bp Haelll fragment cut from the 5' region of the src gene of 
the subclone. 
DNA Sequencing and Analysis of Sequence Data: 
The chemical cleavage method of Maxam and Gilbert [92] 
with the hydroxylamine modification of Schmid and Rubin [108] 
for cleavage at cytosines, was used throughout. Fragments to 
be radioactively labeled were generated by cleavage with res-
triction enzymes which produce 5' protruding ends. The 5' ends 
were radioactively labeled using T- polynucleotide kinase and 
32 
gamma-[ P]-ATP as described above. To obtain DNA fragments 
labeled at a single end, further digestion of double end-
labeled fragments with other restriction enzymes or separation 
of the two DNA strands was performed; both procedures are 
described by Maxam and Gilbert [92]. All regions were se-
quenced at least twice (on both DNA strands, when possible); 
the sequences of restriction enzyme cleavage sites were con-
firmed by DNA sequencing. 
Analysis of DNA sequences for the presence of restriction 
enzyme cleavage sites, or for identification of regions of ex-
tensive homology was facilitated by use of the computer pro-
grams SEARCH and SEQFIT, respectively [128]. 
Bacterial Cells, Phages, and Plasmids: 
Escherichia coli strain ED 8654 [96] was used for isola-
tion and propagation of recombinant bacteriophage. The bac-
teriophage vector lambda gtWES lambda B [82] was used to con-
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struct recombinant bacteriophage. This vector was digested 
with Eco Rl and Sac I, and the Eco Rl arms were purified from 
the dispensable lambda B fragments by sucrose density gradient 
centrifugation. E. coli strain HB101 was used for transforma-
tion and amplification of plasmids [12]. The plasmid pBR322 
[9] was used in the construction of recombinant plasmid DNA. 
The recombinant plasmid clones pSR-REP and pSR-XD were 
generous gifts of F. Cross, The Rockefeller University. The 
construction of these plasmids from pSRA [26] has been 
described [24]. 
Molecular Cloning of Fragments from BH-RSV Proviral DNA: 
550 micrograms of pooled DNA from BH-RSV alpha chicken 
cell clones and 350 micrograms of DNA from BH-RSV beta rat 3Y-1 
cells were completely digested with EcoRI. Digested DNA was 
fractionated on a sucrose gradient, and fractions containing 
the 5 kb viral pol-src fragment were identified by subjecting 
an aliquot of each fraction to agarose gel electrophoresis and 
subsequent hybridization of the Southern blot to src-specific 
probe. For both BH-RSV alpha- and BH-RSV beta-containing DNA, 
the hybridizing band was present in three consecutive frac-
tions; DNA from the fraction with the strongest hybridization 
was concentrated by precipitation in ethanol. The yield was 
approximately 30 and 10 micrograms of 5 kb insert from BH-RSV 
alpha and BH-RSV beta, respectively. 0.075 micrograms of in-
sert DNA was ligated to 1 microgram of EcoRI arms of the phage 
vector, lambda gt WES, (2:1 molar ratio of arms:insert) and 
packaged in an in vitro lambda packaging system [57]. 
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Details of procedures for in vitro packaging [5,57], 
screening [6], phage purification, amplification and prepara-
tion of phage DNA have been previously described [65]. The ef-
ficiencies of packaging of recombinant bacteriophage ranged 
5 6 
from 10 to 10 infectious particles/ug phage DNA. Recombinant 
bacteriophage were plated on 20 x 20 cm "bioassay" plates 
(Nunc) (200,000-400,000/plate) and screened. Before hybridiza-
tion, filters containing phage DNA imprints were prewashed at 
37° in pre-hybridization buffer (5 X SSC (1 X SSC is 0.15 M 
NaCl, 0.015 M Na citrate), 0.02 M Tris-HCl (pH 7.4), and 0.5% 
SDS) for at least 45 min. Hybridization was was carried out at 
37 in hybridization buffer (50% formamide, 5 X SSC, 20 mM 
Tris-HCl (pH 7.4), 0.5% SDS), and at least 200 ug/ml salmon 
sperm DNA for 18-24 hr. Ten ml of hybrid mix containing 2 x 
10 Cerenkov cpm of probe were used for each filter. Following 
hybridization, filters were washed 3 times briefly in 0.2 X 
SSC/0.2% SDS and then incubated once or twice for 45 min each 
at 37 in the same solution. Positive plaques were purified 
three times before amplification. 
Purification of DNA Fragments: 
DNA fragments visualized by ethidium bromide staining of 
agarose or polyacrylamide gels were purified as a result of be-
ing cut out from the gel and electroeluted in dialysis tubing 
containing E buffer. 
Subcloning in Plasmid Vectors: 
The 5 kb EcoRI fragment from BH-RSV alpha and BH-RSV beta 
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was purified from the respective lambda clones and subcloned 
into pBR322 according to standard procedures: phosphatase 
treated EcoRI-cut pBR322 was ligated to equimolar amounts of 5 
kb insert DNA and the ligated products were used to transform 
E. Coli HB101. For in vitro recombination reactions, insert 
and vector fragments (described in the text) were ligated and 
the ligation products were used to transform HB101. 
Transformation of E. Coli was accomplished by addition of 
ligated plasmid DNA to CaCl2-treated bacterial cells [87]; 
transformants were identified by their ability to form colonies 
on agar media containing tetracycline (EcoRI inserts) or ampli-
cillin (EcoRI or Sail inserts). For initial screening of 
clones, plasmid DNA of antibiotic-resistant colonies was iso-
lated from 1-5 ml bacterial cultures by the rapid alkaline 
lysis technique [8]. 
Transfection of CEF with Viral DNA: 
Preparation of CEF and transfection of SR-RSV cloned DNA 
were performed as described [24]. Secondary CEF were seeded 
5 
16-24 hr prior to transfection at a density of 7 x 10 cells/60 
mm culture dish. For the transfection period only, the culture 
medium was replaced with F10 medium lacking Tryptose Phosphate 
broth. Equal quantities (between 0.1 and 1 ug) of pSR-REP DNA 
(or pSR-REP-derived recombinants) and pSR-XD DNAs were cut with 
Sail, ligated briefly (30 min at 16 C, in standard ligation 
buffer with 2 units of T. ligase in 50 ul, at a DNA concentra-
tion of approximately 200 ug/ml) and transfected onto CEF. The 
DNA-calcium phosphate coprecipitate remained on the cells for 6 
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hr; at 6 hrs and again at 18 hrs, the culture supernatants were 
replaced with fresh F10 medium. Cells were passaged on the 
third day post-transfection, overlaid with F10 soft agar medium 
24 hrs later, and monitored for the appearance of characteris-
tic foci. For determination of the titer of infectious viral 
particles in culture supernatants, agar overlay was omitted. 
Isotopic Labeling of Cells and Preparation of Cell Extracts: 
Unless otherwise indicated, cells grown in 65-mm tissue 
culture plates were incubated for 4 hr in 1 ml of methionine-
free minimal essential medium (GIBCO) containing 100 uCi of L-
35 
S-methionine (1200 Ci/mmole, Amersham or New England Nu-
clear) . The cultures were washed twice in cold Tris-Glu buffer 
(25 mM Tris pH 7.4; 135 mM NaCl; 5 mM KC1; 0.4 mM Na2P04; 5.5 
mM glucose), and lysed in 400 ul in slightly modified RIPA 
buffer [13], (0.05 M Tris-HCl, pH 7.4; 0.15 M NaCl; 1% Trition 
X-100; 1% sodium deoxycholate; 0.1% SDS; 1 mM EDTA) containing 
1% Trasylol (a general serine protease inhibitor, FBA Pharma-
ceutical, New York). Lysed cells were scraped from the plate 
with a rubber policeman and transferred to a 1.5 ml Eppendorf 
micro test tube (Brinkman). After vigorous vortex mixing for 
30 sec, the sample was centrifuged in a precooled Beckman Mi-
crofuge B for 4 min. The resulting clarified supernatant was 
used in all subsequent manipulations (100 ul per immunoprecipi-
tation). 
Isotopic Labeling of Virus and Preparation of Virion Extracts: 
For continuous labels, transformed cells grown in 65-mm 
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tissue culture plates were incubated in 1 ml of methionine-free 
minimal essential medium (GIBCO) containing 100 uCi (unless 
35 
otherwise indicated) of L-[ S]-methionine sfor two successive 
12 hr labeling periods followed by a 12 hr incubation in com-
plete medium. Culture supernatants from the three incubations 
were harvested and cell debris was removed by pelleting in a 
Sorval centrifuge (8,000 rpm for 20 minutes). To obtain puri-
fied labeled virions, the clarified supernatant was layered 
over 2 ml of 20% sucrose in a Beckman SW50.1 centrifuge tube. 
Centrifugation at 45,000 rpm for 45 minutes resulted in precip-
itation of virion particles. The virus pellet was resupended in 
100 ul of RIPA buffer containing Trasylol (1%) and used in im-
munoprecipitation experiments. 
For pulse-chase experiments, the labeling times and 
amounts of isotope used are described in the figure legend. 
Unless otherwise indicated, purification of the labeled virions 
was performed as described above. 
Immunoprecipitation: 
Rabbit antiserum raised against total virion proteins 
(anti-virion serum) was a generous gift from Ricardo Feldman, 
The Rockefeller University; antiserum raised against avian 
myeloblastosis virus reverse transcriptase (anti-pol serum) was 
obtained from the Office of Program Resources and Logistics of 
the National Cancer Institute. Preabsorbed serum was prepared 
by adding 10-20 ug of protein from disrupted purified RAV-2 in 
modified RIPA for each 1 ul of anti-pol serum, incubating at 
4 C for 60 min, and spinning out the precipitate in a Beckman 
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Microfuge. Aliquots of cell extracts were incubated with 5 ul 
of unabsorbed serum or 10 ul of absorbed serum for 60 min on 
ice. Three serum volumes of Staphylococcus aureus protein A-
Sepharose CL 4B (Sigma) (a 50% vol/vol slurry in modified RIPA 
buffer) was added and mixed for 30 min at 4 C to adsorb immune 
complexes by the method of Kessler [75]. The Sepharose pellet 
was washed five times in RIPA buffer and twice in H20. The 
pellet was then suspended in 40-100 ul of gel sample buffer 
(62.5 mM Tris (pH6.7), 3% SDS, 10% sucrose, 0.1 M DTT) and 
boiled for 5 min. before loading on a polyacrylamide gel. 
SDS-Polyacrylamide Gel Electrophoresis:. 
Polyacrylamide slab gels (ratio of acrylamide to bisa-
crylamide was 30:0.8) containing 0.1% SDS were prepared accord-
ing to the procedure of Laemmli [80]. Gels were run at 12 to 
20 mA constant current, until the tracking dye reached the bot-
tom of the gel. Gels were fixed briefly and were stained when 
it was necessary to identify unlabeled molecular weight mark-
35 
ers. To locate [ S]-methionine-labeled proteins, fixed gels 
were fluorographed using Enhance (New England Nuclear) accord-
ing to the manufacturer's directions. Gels were dried onto 
filter paper before exposure to film. 
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Chapter 1 
Integration of RSV into chicken cellular DNA 
INTRODUCTION 
Since the integrated proviral DNA of retroviruses is a 
linear non-permuted copy of the viral RNA with LTRs at both 
ends [18,38,62,111], the integration event seems to be highly 
specific with respect to the viral DNA. In this study, BH-RSV 
alpha-infected CEF were used as a model system to determine 
whether there was any specificity for proviral integration on 
host DNA. 
Although the techniques used in this study of proviral in-
tegration were similar to the methods used in the other studies 
of this nature, attempts were made to overcome two difficulties 
encountered in previous analyses of ASV-infected chicken cell 
clones [61,111]: 1) the ambiguity in identification of frag-
ments corresponding to exogenous proviruses, and 2) the lack of 
clonality of the exogenous proviruses found in chicken clones 
grown by conventional methods. The first problem was addressed 
by including in our DNA analyses the uninfected CEF from which 
the infected clones were derived. The second problem was over-
come by the use of BH-RSV alpha as the exogenous provirus. 
The lack of clonality of exogenous proviruses within a 
colony of ASV-infected chicken cells is likely due to virus 
spread and reintegration. Since the BH-RSV alpha strain is de-
fective in the functioning of both the pol and env genes 
[46,47], the virions are therefore non-infectious. A cell in-
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fected with highly diluted BH-RSV alpha should divide and grow 
into a clone in which each cell contains a provirus only at the 
original integration site(s). Therefore, use of this defective 
RSV allows one to examine cells containing one (or few) pro-
viruses without resorting to the use of non-permissive hetero-
logous host cells. Analysis of such BH-RSV alpha-infected 
chicken cell clones showed that, in fact, clonality of proviral 
integration sites was maintained. 
The results presented here demonstrate that expression of 
the viral genes could occur after proviral integration at many 
sites on the chicken genome and that there was no apparent 
preference for specific integration sites. 
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RESULTS 
Restriction Map of BH-RSV 
To determine which restriction enzymes would be suitable 
in studying of BH-RSV alpha integrated proviruses and in 
preparation for eventual molecular cloning of this virus, a 
preliminary restriction map of the provirus was constructed. 
For this purpose I used a clonal line of 3Y-1 rat cells which 
contained integrated provirus from BH-RSV beta [69] as a source 
of DNA. 
EcoRI sites in BH-RSV. EcoRI cuts within the LTR of Rous 
sarcoma and avian leukosis viruses [26,38,54,58,65,118,139]; 
therefore, this enzyme is very useful for mapping studies since 
it generates the same internal proviral fragments regardless of 
the cellular site of integration. 
The EcoRI site in the env gene of other Rous sarcoma and 
avian leukosis viruses was not present in BH-RSV. Digestion of 
BH-RSV-infected 3Y-1 rat DNA with EcoRI yielded two fragments 
of approximately 2.5 and 5.0 kb which hybridized to viral se-
quences (Fig. 1.1, lane 1). Similar digestion of SR-RSV DNA 
yields three fragments of 2.5, 3.8, and 3.2 kb. Since the BH-
RSV 2.5 kb fragment comigrated with the 2.5 kb EcoRI fragment 
from cloned SR-RSV DNA, hybridized to cDNA-,, and did not hy-
bridize to pol probe (data not shown), this fragment appeared 
to be identical to the 2.5 kb gag-containing EcoRI fragment 
identified in other Rous sarcoma and avian leukosis viruses. 
The ~5.0 kb fragment appeared only in EcoRI digests of BH-RSV 
Figure l_.l.. BH-RSV-infected rat cellular DNA digested with 
restriction enzymes and hybridized to viral probes. Samples 
containing of 10 ug of total cellular DNA were digested with 
the restriction endonucleases specified below, subjected to 
electrophoresis on agarose gels, and transferred to nitrocellu-
lose paper as described in the text. The blots were then hy-
bridized to the viral probes specified below. The positions of 
the lambda DNA molecular weight markers run in a parallel lane 
are indicated on the left. Size values are expressed in kilo-
bases. Lane 1, EcoRI digestion, hybridized to RAV-2 probe; 
lane 2, EcoRI-HindIII double digestion, hybridization to RAV-
2 probe; lane 3, EcoRI-SacI double digestion, hybridization 
to ^ A V"2 r e_ probe; lane 4, EcoRI-Kpnl double digestion, hybrid-
ization topRAV-2 probe; lane 5, EcoRI-Kpnl double digestion, 
hybridization to LTR probe; lane 6, EcoRI-Kpnl double diges-
tion, hybridization to src probe. Lanes 5 and 6 were rehybrid-














DNA, whereas the two fragments of 3.8 and 3.2 kb normally 
present in EcoRI digests of RSV DNA, did not appear in this 
virus strain. The 5.0 kb fragment hybridized to pol and src 
probes, and did not hybridize to cDNA^, (data not shown); the 
size and genetic content of this new fragment is consistent 
with its being a fusion of the 3.2 and 3.8 kb fragments, minus 
the env sequences. 
Mapping other enzyme sites in relation to EcoRI sites. 
For integration studies, restriction enzymes which cleave at 
only a limited number of sites within a provirus are useful. 
DNA extracted from the BH-RSV 3Y-1 rat cells was digested with 
HindIII, Sad, Kpnl, and Pvul, and then hybridized to RAV-2 , 
src, or LTR probes. Digestion with Hindlll, Sad, or Kpnl pro-
duced two large fragments which were detected by both RAV-2 
and LTR probes (data not shown). Therefore, these fragments 
were provirus-cell junction fragments. No viral fragments oth-
er than those detected with LTR probe (i.e., internal frag-
ments) were detected with the RAV-2 or src probe. This is 
rep 
consistent with the hypothesis that HindIII, Sad, and Kpnl 
each have only one recognition site within the BH-RSV provirus. 
The DNA was digested with EcoRI followed by a second 
digestion with Hindlll, Sad, or Kpnl. The fragments resulting 
from the double digestions were compared to those generated by 
single EcoRI digestion. The SacI site mapped within the 2.5 kb 
EcoRI fragment while the Hindlll and Kpnl sites mapped within 
the 5.0 kb fragment (Fig. 1.1, lanes 2-4). In the EcoRI-Kpnl 
digestion, the 5.0 kb fragment was cleaved into a 2.7 kb frag-
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ment which was detected with RAV-2 probe (lane 4) and a 2.4 
rep ^ 
kb fragment detected with LTR (lane 5) or src (lane 6) probe. 
A map of these enzyme sites on the BH-RSV genome is presented 
in Fig. 1.2. For the three enzymes other than EcoRI, the sin-
gle recognition site in BH-RSV corresponded to a site mapped 
previously at the same position on the genome of other strains 
of RSV. However for Hindlll and Sad, a second site assigned 
to env in many RSV strains, was missing in BH-RSV. 
The enzyme Pvul cuts most RSV DNA in the U3 sequences, 
generating a unit length provirus band upon hybrization to 
viral probe [26,38,58,65, 118,138,139]. Although the LTR of 
BH-RSV contained the EcoRI recognition sites, the Pvul sites 
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Figure 1̂ .2̂ . Restriction map of integrated proviral BH-RSV DNA 
compared with RSV DNA. The restriction enzyme cleavage sites 
on the BH-RSV genome were determined by single and double 
digestions, followed by hybridizations to specific viral probes 
as described in the text. Restriction enzyme sites on the RSV 
genome are shown for comparison. The RSV data were compiled 
from previous reports [26,54]. The sizes (in kilobases) of the 
EcoRI fragments of BH-RSV and RSV were determined by agarose 
gel electrophoresis. The broken line and the question mark on 
the BH-RSV genome represents the uncertainty regarding the 
amount of env information in BH-RSV. The boxes at the ends of 
the genomes represent the long terminal repeats of BH-RSV and 
RSV. 
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Analysis of BH-RSV alpha-Infected Chicken Cells: Integration 
Sites in Clonal Cells 
Twelve independent "non-producer" clones were isolated 
from CEF infected with BH-RSV-alpha(RAV-1). Of the 12 clones, 
11 were BH-RSV alpha type, 1 was BH-RSV beta; all 12 produced 
virion particles as well as all the intracellular viral precur-
sor and structural (but not envelope) proteins (data not 
shown). DNA from the 12 clones and from the 2 uninfected em-
bryos from which these 12 clones were derived was extracted and 
analyzed. 
Integrity of the BH-RSV proviruses. DNAs from the 12 BH-
RSV-infected CEF clones and the 2 uninfected chicken embryos 
were digested with EcoRI. Structural integrity of the pro-
viruses was ascertained by the presence of the 2.5 kb and 5.0 
kb internal BH-RSV EcoRI fragments. 
Figure 1.3 (panel A) shows an analysis of cellular DNA cut 
with EcoRI and hybridized to RAV-2 probe. The RAV-2 probe 
was used to avoid detecting the cellular src bands. The same 5 
bands of 15, 11, 8.6, 8.4, and 4.2 kb (the 8.6 and 8.4 kb bands 
run as a doublet) were detected in the two uninfected cell DNAs 
(lanes 1 and 8). Based upon hybridization with specific probes 
(data not shown), and comparison to the known EcoRI maps of the 
avian endogenous proviruses [60], the bands at 15 and 8.4 kb 
were identified as the proviral-cellular junction fragments of 
ev-1, the 11 and 8.6 kb bands as the junction fragments of ev-
4, and the 4.2 kb band as the internal EcoRI fragment of both 
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ev-1 and ev-4. Thus, cells used for infection in this experi-
ment contained the non-expressed endogenous proviruses ev-1 and 
ev-4 as defined by Astrin and others [2,3,53]. 
Clones 2-7 and 10-14 all contained the expected 2.5 and 
5.0 kb internal fragments of BH-RSV. Only in clone 9 was a new 
pattern detected; the 5.0 kb fragment was absent, and instead a 
new band at 12 kb was detected. Since the 2.5 kb band in clone 
9 was normal, the EcoRI site in the left-hand LTR and the 
internal site in gag were both present. This provirus appears 
to have lost the EcoRI site in the right-hand LTR and the 12 kb 
band should contain the remainder of the proviral 5.0 kb frag-
ment linked to flanking cellular sequences downstream (right-
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Number of proviruses and clonality of proviruses. DNA 
from clones 1-14 was digested with EcoRI and hybridized to 
cDNA5,. cDNA5, will hybridize to the 2.5 kb internal fragment 
and to a provirus-cell junction fragment at the 3* end of the 
provirus. The number of new junction fragments in a sample is 
indicative of the number of proviruses present. The results of 
this analysis are shown in Fig. 1.3 (panel B). The bands in 
lanes 1 and 8, which contained DNA from uninfected cells, were 
the LTR-containing fragments of ev-1 and ev-4. The 2.5 kb 
internal fragment was detected in lanes 2-7, and 9-14. One 
unique junction fragment was detected in each sample for lanes 
2-7, 10, and 12-14. The 12 kb junction fragment detected in 
clone 9 with RAV-2 probe (Fig. 1.3, panel A) was not detect-
ed with cDNA,-,; the defect in this provirus must also affect 
the 5' sequences of the right-hand LTR. No junction fragment 
could be detected in clone 11, probably because the fragment 
was too small. Fragments smaller than 0.6 kb would run off 
this gel. Experiments with other enzymes did demonstrate the 
presence of junction fragments in clone 11 (see below). The 
junction fragment of clone 13 is difficult to see due to a par-
tial "dead spot" in the nitrocellulose at that location; on 
longer exposure the indicated junction band became much more 
evident. To verify that the junction fragments in all the sam-
ples were truly unique, similar analyses were performed with 
other enzymes. 
DNA from the 14 samples was subjected to digestion with 
Hindlll, Sad, and Kpnl, all of which cut BH-RSV DNA at only 
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one site (Fig. 1.2). DNA was hybridized to a probe specific 
for the LTR. Since the homology between the U- region of the 
LTRs of exogenous and endogenous viruses is limited [16], this 
probe shows preferential hybridization to exogenous proviral 
sequences. 
As can be seen in Fig. 1.4, the enzyme Hindlll generated a 
unique set of junction fragments in each sample. Analysis with 
SacI and Kpnl gave similar results (data not shown). Occasion-
ally, only one of the two junction fragments in a sample was 
detected when a particular enzyme was used (for example, in 
Fig. 1.4, lanes 11 and 12). This would be expected in cases 
where the second junction fragment is too large (or in the case 
of SacI fragments, too small) to be resolved on the particular 
gel. However, each sample which failed to reveal both junction 
fragments when cleaved with one enzyme, did reveal two junction 
fragments with the two other enzymes tested. Clone 9, which 
was found to be missing the EcoRI site as well as most of the 
5' sequences of the right-hand LTR (Fig. 1.3), apparently re-
tained most of the 3' information in that LTR. We detected 
both right and left-hand junction fragments in clone 9 when LTR 
probe was used on Hindlll, SacI, and Kpnl digestions (Fig. 1.4; 
data not shown). If clone 9 has a deletion it is likely that 
only the last 150 bp of the right-hand LTR are missing from the 
provirus. However, it is possible that the deletion extended 
into the flanking cellular sequences. 
Figure 1..4. Clonal Chicken cellular DNA digested with Hindlll 
and hybridized to the LTR probe. The contents of the lanes, 
the markings on the right, left, and bottom, and the experimen-
tal details were all as described in the legend to Fig. 1.3, 
except that the restriction enzyme was Hindlll and the probe 
was the LTR. The junction fragments which mapped to the right 
end of the BH-RSV provirus are indicated by solid arrowheads; 
the junction fragments which mapped to the left end of the BH-
RSV provirus are indicated by open arrowheads. The order of 
the fragments was determined by rehybridization of this blot to 
other viral probes (data not shown). The extra fragments in 
lane 4 were products of partial digestion. 
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The blots from the Hindlll, SacI, and Kpnl analyses were re-
hybridized to probes for selected parts of the RSV genome (data 
not shown) so that the restriction fragments could be ordered 
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Figure l̂ lL* Restriction maps of the cellular integration sites 
of 12 independent BH-RSV-infected chicken cell clones. 
Cleavage sites for the restriction enzymes were determined by 
digestion of total cellular DNA and hybridization to specific 
viral probes, as described in the text. The scale and genetic 
map are shown at the top. The LTRs are depicted by boxes, as 
described in the legend to Fig. 1.2. The numbers at the ends 
of each line are the clone numbers, as described in the legend 
to Fig. 1.3. The break in the cellular DNA of clone 11 
represents 6 kb. A right LTR is not depicted for the provirus 
in clone 9 since we determined that the provirus was missing 
viral sequences in that region (see text). There may be a 
deletion which spans the last 150 bp of proviral DNA; the dele-
tion may also include an undetermined length of cellular DNA in 




Since the discovery of the site-specific integration 
mechanism of bacteriophage lambda into E. Coli [15,81], many 
investigators have examined the mechanism by which other ele-
ments integrate into their host cells. It has now been esta-
blished that DNA tumor viruses such as SV40 integrate randomly 
with respect to their own genomes as well as the host DNA 
[11,76]. In avian and mammalian retroviruses, the integration 
event has been found to be extremely specific with respect to 
the viral genomes [18,20,38,61,62,111,122], with the LTR prob-
ably playing an important role in this specificity. 
Isolation of RSV-Infected Cells Which Contained Single Pro-
viruses 
The studies reported here re-address the question of 
specificity using an avian retrovirus and its natural host 
cells under conditions which select for initial integration 
events. The virus employed (BH-RSV alpha) contains genetic de-
fects in the pol and env genes. Initial infection was possible 
because both of these essential proteins were obtained from a 
complementing virus. Once infection was established under con-
ditions where cells were infected by a single BH-RSV 
alpha(RAV-l) particle without a helper virus, the only viral 
genome present in the cells was that of the replication-
defective BH-RSV alpha. Thus, multiple infection and virus 
spread were effectively prevented. 
The results of Figs. 1.3B and 1.4 verified that clones of 
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infected chicken cells that harbored only a single provirus 
were obtained. This is in contrast to the results of others 
who were unable to obtain clonal populations of ASV-infected 
chicken cells by conventional methods [61,111]. Although the 
conditions we employed selected for infection by a single virus 
particle, the number of integration events which could be ef-
fected by a single particle was not under selective pressure. 
Our results therefore confirm the notion that single particles 
introduce single integration events. The appearance of multi-
ple proviruses in a clone of infected cells, as has been re-
ported by many investigators [7,38,61,111,129], can be primari-
ly attributed to viral reinfection. 
Expression of Viral Genes and Structure of Proviruses 
The clones described were selected initially on the basis 
of transformed phenotype (src) and subsequently found to be po-
sitive for production of virus particles (gag). Thus, in each 
clone examined, the provirus was capable of supporting expres-
sion of the entire viral genome, regardless of the site of in-
tegration. Furthermore, as determined by restriction enzyme 
mapping, the cloning procedure did not cause the appearance of 
any grossly aberrant proviruses. Clone 9 was found to have a 
defect in its right-hand LTR. The transformed phenotype of 
clone 9 was indistinguishable from that of the other 11 clones, 
as were the levels of intracellular and virion-associated viral 
structural proteins (data not shown). In addition, transform-
ing virus was successfully rescued from a plate of clone 9 
cells superinfected with helper virus. It seems the defect in 
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this provirus did not affect any viral functions. Even if the 
signals for termination and polyadenylation of viral RNA tran-
scripts were affected, there is evidence to suggest that viral 
RNA could be synthesized using cellular signals [151]. 
Lack of Common Integration Sites 
Using four restriction enzymes, we found no similarities 
among the cellular integration sites of the 12 independent 
clones studied (Fig. 1.5). In addition there was no evidence 
of more than one provirus integrating into the same site in op-
posite orientations. Enzymes were found which cleaved at or 
very near the integration site in some but not all clones (Fig. 
1.5). Thus, we conclude that the base sequence 100-500 nucleo-
tides around the integration site differed among the clones. 
However these, as other similar studies, cannot eliminate the 
possibilities that 1) very short sequence similarities exist at 
or near the various possible integration sites, or 2) the pro-
virus recognizes specific cellular sequences but integrates di-
stal to such sites. Since the clones that were studied all 
survived the integration event, it was impossible to determine 
the number, if any, of "forbidden" sites for integration (i.e., 
into vital cellular genes). Within the limits mentioned, we 
detected no apparent preferred or specific acceptor site(s) for 
ASV. This finding supports the conclusion of others: 
No preferential integration has been found in mouse cells 
infected with murine leukemia virus [4,129] or mouse mammary 
tumor virus [18,39]. In the avian system, RAV-0 [64], avian 
myeloblastosis associated virus-2 [7] and reticuloendotheliosis 
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virus [74,122] were found to be non-specifically integrated 
into chicken embryo fibroblasts. With Rous sarcoma virus, 
similar results were obtained in infected rat [19,62], duck 
[38], and quail cells [111]. This report and that of Hughes et 
al. [61] examine integration into chicken cells (the natural 
host). 
The results presented in this report confirm and extend 
the findings of Hughes et al. Under conditions which select 
for initial integration events, Rous sarcoma virus integrated 
into chicken DNA at no preferred sites. In addition, expres-
sion of the proviral genes was shown to be compatible with pro-
viral integration at multiple sites. 
Recently, DNA fragments containing proviruses and the 
flanking host DNA have been molecularly cloned and examined. 
DNA sequence analyses of proviruses of several avian and mam-
malian retroviruses have revealed the consistent presence of a 
4-6 bp duplication of host DNA at the site of integration 
[27,56,63,86,121,124]. There does not seem to be any specifi-
city with regard to the sequence of the integration site (i.e., 
the repeated nucleotides), although the number of nucleotides 
which are duplicated seems to be characteristic of the retro-
virus species and may reflect the involvement of a virally en-
coded function (possibly pl9 or reverse transcriptase) in the 
integration process. 
Keshet and Temin proposed that integration can occur at 
multiple sites in the genome, but biological expression of the 
proviral genes can only occur via integration at a "limited" 
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number of sites [74]. We found twelve expressed proviruses in-
tegrated at twelve different sites. Thus, this "limited" 
number, if it exists, must be significantly larger than twelve. 
Oncogenesis by avian leukosis virus involves a "promoter-
insertion" mechanism [97]. Although avian leukosis virus can 
express all its replicative functions via random integration, 
Neel et al. found that in avian leukosis virus-induced tumors, 
the proviruses were all integrated at a specific site. In 
light of their results, it seems likely that viral integration 
at specific sites would be found only in cases where there is 
selection for expression of a function which is not encoded on 
the viral genome (such as tumor formation by avian leukosis 




Genetic structure of BH-RSV: 
The pol-src junction and the src-U~ region 
INTRODUCTION 
Both BH-RSV alpha and beta have been used extensively in 
genetic analyses of RSV. The pol and env defects have been 
well characterized biologically; to complete the biochemical 
characterization of the defects in the BH-RSV strains, DNA 
fragments containing the defective regions were molecularly 
cloned and analyzed. 
In this study, I examined the sequence of the pol-src re-
gion of BH-RSV to determine whether residual env coding infor-
mation was present on the BH-RSV genome. The mechanism of gen-
eration of this deletion is not known, and the regions flanking 
the deletion were examined for the presence of homologous se-
quences which may facilitate the process of deletion. 
Recent DNA sequencing of the src genes of two other 
strains of RSV, SR- and PR-RSV, revealed the presence of direct 
repeats and other features in the non-coding regions flanking 
the 5* and 3' sides of src [117,135,136]. The sequence of the 
homologous region in BH-RSV was determined in an attempt to 
gain insight into the recombination events which resulted in 
transduction of the c-src gene into a retrovirus. 
The sequence of BH-RSV was also examined in an effort to 
obtain information regarding the genesis of BH-RSV. Because of 
uncertainties in the passage history of the RSV strains (see 
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introductory chapter), it is not actually known whether BH-RSV 
was a deletion mutant of a non-defective RSV or an independent 
recombinant between a helper virus and c-src. 
The results indicated that essentially the entire env and 
5' flanking region of src were absent from BH-RSV. Comparisons 
between BH-RSV sequences and other retrovirus sequences, re-
vealed the presence of two regions of highly conserved non-
coding sequences. The origin of BH-RSV could not be determined 
since the sequence did not provide strong evidence for either 
the env deletion or independent recombinant model. 
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RESULTS 
Analysis of Molecular Clones of BH-RSV 
Molecular Cloning of 5 kb pol-src fragment of BH-RSV alpha 
and beta. The 5 kb EcoRI fragment of BH-RSV alpha and beta was 
cloned from the infected cells which were used in the integra-
tion study (chapter 1). DNA from BH-RSV alpha chicken cell 
clones 2-7 and 10-13, and DNA from BH-RSV beta rat 3Y-1 cells 
were completely digested with EcoRI, fractionated on a sucrose 
gradient, and DNA fractions containing the 5 kb viral pol-src 
fragment were cloned into the EcoRI site of the phage vector, 
lambda gt WES. For both BH-RSV alpha and BH-RSV beta, a lambda 
clone containing the 5 kb EcoRI pol-src fragment was isolated 
and purified. In order to increase the ratio of insert DNA to 
vector DNA, the 5 kb viral fragment was subcloned into the 
EcoRI site of the plasmid pBR322. Plasmid clones containing 
the 5 kb fragment from either BH-RSV alpha or beta were isolat-
ed; one clone of each, refered to as pBH-alpha or pBH-beta, was 
chosen for further analysis. The structure of these plasmid 
clones is shown in Figure 2.1. 
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Figure 2^1^ Structure of BH-RSV molecular clones. The upper 
portion of the circles represent the 5 kb EcoRI viral insert 
fragments. The lower portion represents pBR322 sequences (4.3 
kb). Restriction enzyme sites which are indicated are: E, 
EcoRI; K, Kpnl. 
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Restriction enzyme cleavage analysis of pBH-alpha and 
pBH-beta. Based on the nucleotide sequence of the entire 
genome of PR-RSV [117] and the env-src EcoRI fragment of SR-RSV 
[134], restriction enzymes with cleavage sites in env were 
selected for analysis of the BH-RSV genome. Figure 2.2 shows 
some of the restriction enzyme cleavage data for pBH-alpha and 
pBH-beta. 
To orient the DNA fragments which were obtained by diges-
tion with the various restriction enzymes, secondary digestion 
with the enzyme Kpnl was performed. The single Kpnl site is 
located approximately 200 bases before the stop codon of pol in 
PR-RSV, essentially dividing the genome into a gag-pol half and 
an env-src half. Kpnl digestion of the 5 kb pol-src EcoRI 
fragment of BH-RSV yielded two fragments of approximately 2.7 
and 2.4 kb which represent the left and right halves, respec-
tively, of the 5 kb fragment (lane K, see also Figs. 1.1 and 
1.2). 
The order and identity of the restriction fragments shown 
in the gels in Fig. 2.2 was determined by comparison of single 
and double digests, comparison of the sizes of the BH-RSV frag-
ments to those of SR- and PR-RSV, and hybridization of a South-
ern blot of the gel with src specific probe (not shown). 
Figure 2̂-2̂ . Restriction enzyme cleavage analysis of pBH-alpha 
and pBH-beta. The 5 kb EcoRI viral insert fragments were dig-
ested with enzymes as described below and subjected to electro-
phoresis through 1.5% agarose in a "mini gel" apparatus. Gels 
were stained with ethidium bromide. In lanes marked mw, the 
first lane was a Hindlll digest of lambda DNA and the second 
lane was a HinfI digest of pBR322 DNA. The markings on the 
left indicate the positions of the 4.3, 2.0, 1.6, and 0.5 kb 
markers. K, Kpnl digest of pBH-beta insert. Lanes marked with 
names of enzymes: in each set of 4 lanes, the first and third 
lanes were pBH-alpha insert DNAs and the second and fourth 
lanes were pBH-beta insert DNAs. The first and second lanes 
were single digests with the indicated enzyme and the third and 
fourth lanes were double digests with the indicated enzyme and 
Kpnl. The faint band at 4.3 kb in many lanes was pBR322 DNA. 
Enzymes used were AccI, Ncol, and Nael (upper left); Ball, 
PvuII, and BamHI (lower left); and Bgll and Xhol (right). 
mw, Bgl , Xho , K 
mw Bal . Pvu , Bam , K 
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The individual restriction enzyme fragments which were 
cleaved by secondary digestion with Kpnl were identified as 
fragments which span the pol-src junction. BH-RSV fragments 
which were contained wholly in pol or src were found to be the 
same size as the corresponding fragments of SR- or PR-RSV, with 
the exception of: 1) An Xhol site, not found in PR- or SR-RSV, 
was present in the pol gene of BH-RSV, approximately 800 bp 
from the 5' end of the 5 kb insert of pBH-alpha and pBH-beta 
(note the 800 bp band in Xhol digests shown in Figure 2.2) 2) A 
PvuII site in pol, present in PR-RSV, was not found in either 
pBH-alpha or pBH-beta. 3) A second BamHI site, mapping near 
the 3* end of the PR-RSV pol gene, was not present in pBH-alpha 
or pBH-beta. This site is also not present in SR-RSV [26]. 
However, an additional BamHI site mapping near the 5' end of 
the pol gene was found in pBH-beta. This site was not present 
in pBH-alpha (note the different patterns for BamHI digestion 
of pBH-alpha and beta), SR-RSV, or PR-RSV. 
Except for BamHI digests, restriction fragments of both 
pBH-alpha and pBH-beta comigrated indicating that the addition-
al pol defect in BH-RSV alpha was probably not due to a large 
deletion or major sequence rearrangement. (The apparent differ-
ence between the digestion patterns of pBH-alpha and beta with 
the enzyme Nael was not consistently observed and was believed 
to be an artifact in this particular reaction). 
The results obtained from the restriction enzyme cleavage 
analysis are summarized in Figure 2.3. All the restriction en-
zyme sites which map in pol or src (with the exception of the 
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few discussed above) were present in BH-RSV. All the restric-
tion enzyme sites which map in either env or the intercistronic 
region between env and src were absent. The Ncol site, shown 
in the figure to map at the border between the intercistronic 
region and src, was present in BH-RSV. This cleavage site in-
cludes the ATG initiation codon (recognition site for Ncol: 
CCATGG) of the PR- and SR-RSV src genes; the presence of the 
Ncol site in BH-RSV suggests that the src coding region is in-
tact in BH-RSV. 
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Figure 2.3. Restriction enzyme cleavage map of BH-RSV compared 
to non-defective RSV. Positions of restriction enzyme cleavage 
sites on the RSV genome between the EcoRI site in gag and the 
EcoRI site in U^ are indicated. Enzyme sites in pol and gp85 
were based on the PR-RSV sequence [117] and sites in gp37 
through U~ were based on the SR-RSV sequence [134]. The env 
gene was drawn to a larger scale. A (+) or (-) sign below a 
position indicates whether the site was present or absent in 
BH-RSV; the map refers to both BH-RSV alpha and beta. Dotted 
line marking an enzyme site indicates a site which was present 
in BH-RSV but not present in PR-RSV. An extra BamHI site which 
was present in BH-RSV beta only (see text) is not shown; it 
mapped between X and Xb in the 5' portion of pol. Enzymes were 
E, EcoRI; Hp, Hpal; Hi, Hindlll; X, Xhol; Xb, Xbal; Ba, BamHI; 
Bl, Ball; N, Ncol; P, PvuII; A, AccI; Bg, Bglll; K, Kpnl; B, 
Ball. 
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Sizing of a pol-src junction fragment. To further examine 
the extent of the missing env sequences in BH-RSV alpha and 
beta, the size of the pol-src junction fragment, bounded by the 
Kpnl site in pol and the Ncol site at the 5* end of src, was 
determined. As shown in Figure 2.4, the Kpnl-Ncol fragment in 
BH-RSV was approximately 300 bp. The homologous fragment of 
PR- or SR-RSV would be approximately 2.2 kb. If the 3' end of 
the BH-RSV pol gene is similar to that of PR-RSV, it would be 
expected that following the Kpnl site would be 200 bp of pol, 
thus allowing for no more that 100 bp of env or intercistronic 
sequences in BH-RSV. 
As can be seen in Figure 2.4, the Kpnl-Ncol fragment of 
BH-RSV alpha and BH-RSV beta comigrate, suggesting that the pol 
defect in BH-RSV alpha is not due to an extension of an env 
deletion into the pol gene. 
Figure 2^4. Ncol-Kpnl double digests. 5 kb insert of pBH-
alpha or pBH-beta was digested with Ncol followed by: (left 
panel) 5' end-labeling with P and secondary digestion with 
Kpnl, or (right panel) secondary digestion with Kpnl. Electro-
phoresis was performed on 5% polyacrylamide gels; molecular 
weight markers shown in rightmost lane were Hinfl digests of 
pBR322 DNA. Panel on left was an autoradiogram, panel on right 














DNA Sequence Analysis of BH-RSV 
Sequence of the pol-src junction in Bryan RSV. The 300 bp 
Kpnl- Ncol fragment was partially sequenced by the method of 
Maxam and Gilbert [92] according to the strategy depicted in 
32 
Figure 2.5. The Ncol 5' end was labeled with P in a kinase 
reaction and sequencing in the reverse direction (non-coding 
strand) from the initiation codon of src revealed that there 
were only 97 bp between the end of pol and the beginning of src 
in BH-RSV (Figure 2.5). The 91 nucleotides preceding src in 
BH-RSV were found to be essentially identical to the 91 nucleo-
tides preceding src in PR- and SR-RSV, in recombinant rASV 1441 
[136], and in c-src [135], the cellular homolog of the viral 
src gene. This 91 bp region contains the putative splice ac-
ceptor site (SA) for src mRNA, mapped to position -74 relative 
to src [117,136]. 
Immediately preceding this 91 bp region (SA region) in 
BH-RSV was the sequence identified as the end of the pol gene, 
including the stop codon TAA and 6 nucleotides which follow pol 
in PR-RSV. The pol-src junction sequence was confirmed by 
sequencing using a Ddel site as the labeled end; partial 
sequencing of the 3' end of the BH-RSV pol gene confirmed that 
the sequence was essentially identical to that of PR-RSV. 
A helper virus-related sequence, which is present between 
env and src and repeated between src and the LTR in both SR-
and PR-RSV, was not present in the region 5' of src in BH-RSV. 
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(A) 
Compared to end of POL 
BH-RSV: N.D. 
POL-SRC REGION OF BH-RSV 
)ACATCACCCAAAAGGATGAGGTGA(ND)GAAAGATGAGGYGAGCCCTCTTTTTGCAGGCATTTCCGACTGGATACCCTGGGGAGACGAG 
PR-C: GGTACCCTCTCGAAAAGTTAAACCGG************************CTM***********C************** 
Kpn I Dde I 
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Figure 2_. _5. DNA sequence of 300 bp Ncol-Kpnl fragment of BH-
RSV. (A) BH-RSV sequence from Kpnl site to end of pol gene 
compared to sequence of homologous region of PR-RSV [117]. (B) 
BH-RSV sequence from the end of pol to the Ncol site, compared 
to sequence upstream from src in PR-RSV [117], SR-RSV [134], 
rASV 1441 [136], and c-src [135]. Termination codon of pol in 
BH-RSV is underlined. In (A) and (B), * indicates the same nu-
cleotide as BH-RSV and (N.D.) indicates sequences which were 
not determined. (C) Highlight of the pol-src junction in BH-
RSV. (D) Schematic showing region sequenced and strategy used. 
Asterisk with arrow indicates position of pol-src junction as 
determined by DNA sequencing. Enzymes: K, Kpnl; D, DdeI; H, 
Hpal; N, Ncol. 
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—' e n d of Bryan RSV. Preliminary restriction enzyme map-
ping analysis indicated that the last 500 bp of pBH-beta were 
similar to the corresponding region of SR-RSV except for a 
short region immediately following the src gene. In this re-
gion, BH-RSV did not contain the restriction enzyme cleavage 
sites present in the corresponding region of SR-RSV (Figure 
2.6). Hybridization experiments indicated that neither the se-
quence termed "F3" (found on the 3* end of SR-RSV) nor "F2" 
(found on the 3* end in PR-RSV) [135] were present in BH-RSV 
(data not shown). 
The 3' end of the BH-RSV beta, from the last 70 bp of src 
to the EcoRI site in the U , , . . 
_ region, was sequenced according to 
the strategy depicted in Figure 2.6. The results (Figure 2.7) 
show an overall similarity between the BH-RSV sequence and the 
corresponding SR-RSV sequence, with one major exception. Im-
mediately following the stop codon of src, the next 118 nucleo-
tides of BH-RSV and SR-RSV were completely different. Except 
for a few single base changes, and a 12 bp repeat present in 
BH- and not in SR-RSV, the remainder of the sequence was the 
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Figure 2.6. Comparison of the 3' end of BH-RSV and SR-RSV. 
Positions of restriction enzyme cleavage sites in the region 
between the end of src and the U^ region are shown. SR-RSV 
sites are based on DNA sequence in ref. 134. BH-RSV sites 
based on restriction mapping analysis of pBH-beta. Strategy 
for sequencing this region of BH-RSV is shown at the bottom of 
the figure. Enzymes: M, Mstll; D, Ddel; R, Rsal; PII, PvuII; 
A, Alul; Hh, Hhal; Hf, Hinfl; HII, Haell; N, Nrul; S, Sau3A; P, 








[ Fl-A ][ Fl-B 
BH-RSV: GTGGGGAGGGCAAGGCTTGCGAATCGGGTTGTAACGGGCAAGGCTTGACTGAGGGGACAATAGCATGTTT 
SR-RSV: T*A**CGCTTTGC*CTGCTTCGCGAT*TAC*GCCA*ATAT*C**G*AT**********T*GG*TG***** 
Fl-B ][ Fl-C ][ Fl-D 
BH-RSV: AGGCGAAAAGCGGGGCTTCGGTTGTACGCGGTTAGGAGTCCCCCCTCAGGATATAGTAGTTTCGCTTTTG 
SR-RSV: ********************************************************************** 
][ PPT ][ U3 begins 
BH-RSV: CATAGGGAGGGGGAAATGTAGTCTTATGCAATACTCTTGTAGTGTTGCAACATGCTTATGTAACGATGAG 
SR-RSV: ******** p^**********************************Q************************** 
BH-RSV: TTAGCAACATGCCTTATATGGAGAGAAAAAGCACTGTGCACGCCGATTGGTGGAAGTAAGGTGGTATGAT 
SR-RSV: *************** Q* *********** *****Q*****^****************** ****** *Q** * 
EcoRI 
BH-RSV: CGGTGGTATGATCGTGCCTTATTAGGAAGGCAACAGACGGGTCTGACACGGATTGGACGAACCACTGAATT 
SR-RSV: * ******************************* ****^** ******* p^******Q***** 
Figure 2.]_. DNA sequence of the 3 ' end of BH-RSV compared to 
homologous region of SR-RSV. Amino acids shown represent car-
boxy terminal residues of src. ###, termination codon of src. 
F1A-F1D, see text for explanation. PPT, polypurine tract. *, 
same nucleotide as BH-RSV. Blank space indicates nucleotide 
not present in SR-RSV. 
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Conservation of a helper virus-related sequence in avian 
retroviruses. One copy of "Fl", the sequence present as a 
direct repeat on either side of src in SR- and PR-RSV 
[117,134], was found on the 3* side of src in BH-RSV (Fig. 
2.7). Comparison of the two copies of Fl in SR- and PR-RSV in-
dicated that the sequence seemed to be composed of discrete 
blocks of conserved sequences which I termed Fl A-D. 
Since the Fl sequence is also present between env and U~ 
in RAV-0 [59], Fl is believed to be of helper virus origin. 
Examination of the DNA sequence of several avian retroviruses 
revealed the remarkable fact that the Fl sequence is present 
immediately upstream from U • *• -^ • v. . t. 
j.nuu^^j.cn-cxjr u^oi_j.com ±x.wm w i n every virus for which the se-
quence in this region is known [77,78,110,117,120,134]. Figure 
2.8 shows the Fl sequence present in RAV-O, PR-RSV, SR-RSV, 
AMV, FSV, Y73 and BH-RSV. In addition, Fl is also present in 
evl, ev2, and RAV-2 [A.M. Skalka, et al personal communica-
tion]. Fl is not present in murine retroviruses [123]. 
Figure 2.8. Comparison of the Fl sequence of RAV-0 with that 
of several avian transforming retroviruses. RAVO: RAV-O; se-
quence shown is 3* end of env through U3 [59]. Z, sequence 
between the termination codon of env and start of Fl in RAV-O. 
Other regions are the same as described in legend to Figs. 2.7 
and 2.8. 5'SR and 5'PR: 5* side of src in SR- and PR-RSV 
respectively. Sequence shown is the 3' end of env through the 
env-src intercistronic region [117,134]. 3'BH, 3'SR, and 3'PR: 
3' side of src in BH-, SR-, and PR-RSV respectively. Sequence 
shown is downstream of src through U-. [Fig. 2.7 and 117,134]. 
In AMV, Y73, and FSV the sequence shown is downstream of the 
one sequence through U- [77,78,110, 120]. *, same nucleotide 
as RAV-O; blank space indicates a nucleotide which was not 
present. Inserted nucleotides are indicated. 
R A V> enw / 3 C z DC FI-A 
RAVO: AGGCAGCCCGAAAATGGAGCAGTGTAAAGCAGTACATGGGTGGTGGTATGAAACTTGCGAATCGGGCTGTA 
5 'SR: G*******T****GCA**AT***A***G*********************AGCG****T**G*****T**** 
5'PR: ***A**ATGC*GGGC********C**G*** TCA**TA**AT**T*C**************** 








5'SR: ********T*****A***A*********TG*C***********J**** ***** **j*** *ACG**AC ** 
5 'PR: *************** **c* ******** *T* AC** ************ A** *** *TC* ****** **J*** *C** 
AMV: *****************c**********T*AC**************A******TC*********l****C** 
3 'BH: *****CA*G*CA**************A*T**C****T*********A************************ 
3 ' SR: CCA*ATAT*C**G*AT************GG**G***T*********A************************ 
3'PR: *TAAT*TGCA*T**************C*TGA*G**********TC*A**********************A* 
Y73: *****^********************C*T**C**************A************************ 
PSV: *****T**G*I |***********c*TG*************CT************************** 
AGTGAGTAGTATA 
][ Fl-C ][ Fl-D ][ PPT ][ U3 begins 
RAVO: AGGAGTCCCCTCAGGATATAGTAGTTGCGCTCTTGCATAGAGAGGGGGAAATGTAGTCAAATAGAGCCAGA 
5'SR: ***********T************ACA****T*******TGTTACATA*CT*CCCTGTTTTGCCCTTAGAC 
5 «pR: ****J********GA*G***G*C**A*AT************G*G* AAA**********TT*ATATTGTCTG 
AMV: ****.* *******GA*G***Q*c**A*Afr***ip********G*****************T***c*TAGGTT* 
3 'BH: ************************ ***T** * *T** ***** *G **************** *TT**GC*ATACTC 
3 'SR: **********J****************T****T********G**A**************TT**GC*ATACTC 
CC , , 






Comparison of the sequences flanking src in various RSVs. 
Figure 2.9 summarizes the relationship between the flanking re-
gions of BH-RSV and those of two other RSVs and a helper virus. 
In contrast to the other RSVs, BH-RSV does not have any flank-
ing sequences 5' of the src gene. The 91 bp SA region is 
directly linked to the end of pol. On the 3' side of src, BH-
RSV has one complete copy of the RAV-O Fl sequence. The first 
copy of the SR- and PR-RSV Fl sequence (on the 5' side of src) 
seems to be complete; however the second copy of Fl (on the 3' 
side of src) in these sarcoma viruses lacks the Fl-A region. 
In PR-, SR-, and BH-RSV, the ~120 nucleotides immediately fol-
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DISCUSSION 
Env Deletion in BH-RSV. 
On the basis of DNA sequence data (Fig. 2.5), I estimate 
the deletion in BH-RSV to be approximately 1.9 kb. The exact 
number of nucleotides which are deleted can not be determined 
because of the variation in the size of this region in dif-
ferent non-defective RSVs (Fig. 2.9). The sequence data are in 
good agreement with previous size estimates based on restric-
tion enzyme mapping analysis (i.e., 2 kb) [118]; however the 
deletion is slightly more extensive than the estimate reported 
on the basis of oligonucleotide fingerprinting analysis (i.e., 
1.5 kb) [30]. 
Sequencing revealed the gp85 and gp37 coding sequences to 
be completely absent from BH-RSV. Only the portion of the env 
signal sequence which overlaps with the 3* end of pol (in 
another reading frame) [see 117] as well as 6 bp which follow 
the pol terminator were present in BH-RSV. Since the putative 
splice acceptor site for env mRNA maps within the 3' end of 
pol, BH-RSV may, in fact, synthesize 2 species of 21S src-
containing mRNA which differ by ~135 nucleotides. (The larger 
mRNA species would not be expected to direct the synthesis of a 
src-related protein since it would be translated in a different 
reading frame than src; this reading frame is also interupted 
by several termination codons in the pol-src junction). In ad-
dition to the absence of env, the Fl sequence or other flanking 
sequences were not present upstream from src. The region 
between pol and src in BH-RSV, therefore, does not share any 
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homology with ALV and this may explain the inability of BH-RSV 
to recombine with ALV to generate a non-defective RSV [70]. 
The sequence surrounding the pol-src junction of BH-RSV 
was examined for sequence information which may shed light on 
the mechanism of such a deletion. src gene deletions occur 
with high frequency in RSVs resulting in the formation of tdRSV 
mutants [70] and examination of the DNA sequence surrounding 
the src gene suggests a mechanism for this deletion. In both 
PR- and SR-RSV strains, the Fl sequence is repeated on the 5' 
and 3' sides of the src gene [17,134]; homologous recombination 
between the two Fl's would result in loss of all sequences in 
between, including src. Uniformity in the size of many in-
dependently derived td isolates [31] as well as DNA sequence 
data [151] supports this hypothesis. (However, partial tds 
with smaller src deletions [73] were most probably generated by 
other mechanisms.) 
Examination of the sequence surrounding the pol-src junc-
tion in BH-RSV and comparison to other available sequence data, 
did not reveal any obvious sequence homologies which would sup-
port the notion that a deletion occurred by homologous recombi-
nation. In PR-RSV the sequence immediately following pol (TTA-
TATTCTC) shares 8 out of 10 bp with a sequence upstream from 
src (TAATATTGTC, -97 to -88 relative to PR-RSV src). A homolo-
gous recombination occurring within the 5 bp homology (ATATT) 
in these two regions would generate a the sequence of the pol-
src junction. However, it is unlikely that such a short homol-
ogy, 5 bp within an otherwise non-homologous sequence, could 
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account for the BH-RSV deletion. This would be equivalent to 
proposing that restriction fragments could be deleted by "homo-
logous recombination" between cleavage sites, a phenomenon that 
has not been reported to occur. 
Although the DNA sequence of the pol and env genes of SR-
RSV is not available, comparison of the sequence at the end of 
PR-RSV pol with the sequence upstream from SR-RSV src revealed 
only a 2 bp homology with the BH-RSV pol-src junction. There-
fore, on the basis of sequence data available at the present 
time, it appears unlikely that the BH-RSV gene structure is a 
result of deletion by homologous recombination. However, be-
cause of the limited amount of available DNA sequence data on 
pol and env, we are still unable to rule out this possibility. 
One approach to determine whether there is a feature in-
herent in the sequence which renders the env region susceptible 
to complete deletion would be to examine the pol-src junction 
of other deletion mutants. SR-NY8 is an env-deletion mutant 
derived from SR-RSV [71]. Studies are currently in progress to 
determine the extent of the deletion in this strain. An ident-
ical or similar pol-src junction would suggest a common mechan-
ism of deletion. 
The 3' End of BH-RSV. 
The sequence of the 3' end of BH-RSV failed to demonstrate 
a relationship between BH-RSV and either of the two non-
defective viruses, PR- or SR-RSV (Figs 2.7 and 2.9). Although 
this may suggest that BH-RSV did not derive from either of 
these strains by deletion of env, these sequence data are in-
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sufficient to conclude that BH-RSV is an independently derived 
defective sarcoma virus. Too few viruses have been sequenced 
thus far and general conclusions about the origins of the vari-
ous strains cannot be drawn at this time. 
Retroviruses have been observed to undergo recombination 
at a very high rate when mixtures of viruses are passaged or 
when virus is passaged through cells containing endogenous 
viral information [48,70]. Because the passage history of the 
RSV strains involved several decades of in vivo passage, it is 
very important to examine the sequences of endogenous pro-
viruses and several helper viruses. Portions of the RSV genome 
which were not subjected to selective pressure may have been 
derived from endogenous or helper viruses by recombination. In 
fact, it has come to our attention that the BH-RSV sequence 
between src and the EcoRI site in U- is also found in RAV-2 
[Bizub and Skalka, personal communication]. It is very in-
teresting to note that RAV-2 was originally isolated as a 
helper virus in BH-RSV stocks [41]. The differences in the 
non-coding regions of BH-, PR-, and SR-RSV may therefore re-
flect the nature of passenger helper viruses more than the ori-
gins of the transforming viruses. 
Conservation of a 91_ b£ Region Preceding src. 
Takeya and Hanafusa reported that the sequence of the c-
src exons is highly conserved in the v-src genes of SR-RSV and 
rASV 1441, and that the sequence conservation includes 91 bp of 
non-coding information immediately preceding c-src [134,135]. 
It was therefore proposed that position -91 relative to the 
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start of c-src represents the site at which recombination oc-
curred between a helper virus and the c-src gene to generate 
the the transforming virus, RSV. Additionally, it was suggest-
ed that this same position was involved in the recombination 
events which resulted in the generation of rASV by recombina-
tion between tdRSV and c-src [134]. Remarkably, the pol-src 
junction in BH-RSV occurs at the very same position, -91 rela-
tive to src (Fig. 2.5). Examination of the sequence data re-
veals that BH-, PR-, and SR-RSV have essentially the same nu-
cleotide sequence from position 0 to -91 relative to src; 
upstream from this point the three RSVs diverge from each other 
and from c-src. 
Some implications of this finding include: 1) Conservation 
of this sequence would suggest a functional requirement for 
this entire region. Position -91 is approximately 12 bp 
upstream from a splice acceptor "consensus sequence" [83] which 
has been proposed to be the acceptor site for src mRNA 
[117,136]. Deletions extending into the consensus sequence and 
beyond may impair the the virus' ability to synthesize a func-
tional src gene product. 2) If BH-RSV is an independent defec-
tive sarcoma virus, it would appear that the identical site in 
c-src could participate in recombination events with helper 
virus at (at least) two different sites on the helper virus 
genome. 
In either case, it is not clear what structural feature or 
other property is inherent in the DNA sequence in the vicinity 
of -91 to make it such a "hot spot" for recombination and/or 
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deletion. 
Conservation of the "Fl" Sequence. 
The striking conservation of this ~125 bp non-coding se-
quence in so many avian retroviruses would suggest a functional 
role for this sequence. Mutants of tdRSV with deletions in Fl 
have been constructed in vitro and deletion of most of Fl (only 
Fl-D and part of Fl-C remained) did not affect viral replica-
tion [123]. However, a deletion of the entire Fl extending 
into the polypurine tract abolished replication. These results 
support a functional role for either the polypurine tract or 
the last 15 bp of Fl; the role of the bulk of Fl is at present 
unclear. 
Undoubtedly, the presence of Fl in so many viruses facili-
tated recombination between various avian retroviruses. 
Viruses which were passaged together may have freely exchanged 
Fls and neighboring regions. Preliminary evidence [Bizub and 
Skalka, personal communication] suggests that such recombina-
tion occurred between BH-RSV and its helper virus, RAV-2. Ex-
amination of the Fl sequences in Fig. 2.8 reveals the fact that 
the Fl sequences of AMV and PR-RSV (between env and src) are 
remarkably similar, suggesting they may have once been passaged 
with a common helper virus. 
RAV-60s are recombinant ALVs which contain an env gene ac-
quired (in whole or in part) by recombination with endogenous 
viral sequences [48,52]; the U~ region, however, is derived 
from the exogenous virus [23]. BH-RSV does not contain any se-
quences which are homologous to env but can give rise to RAV-
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60s which have the src gene replaced by subgroup E env [48]. 
Generation BH-RSV-derived RAV-60s by recombination between BH-
RSV and an ev provirus would, therefore, most likely involve 
crossing-over at homologous sites in the Fl sequence of BH-RSV 
and ev genomes. Another cross-over point in a homologous re-




The pol defect of BH-RSV alpha 
INTRODUCTION 
The pol gene is probably the most poorly understood of the 
retroviral genes. Its mRNA transcript has yet to be isolated 
(see introductory chapter), the processing pathway of the gag-
pol precursor has not been directly shown, and the relationship 
between processing and virion assembly remains unclear. A 
number of functions have been attributed to the pol gene pro-
duct: several enzymatic activities [115,142], roles in selec-
tion and packaging of cellular tRNAs [102,104,113], and a 
suspected role in integration of viral DNA. Unanswered ques-
tions still remain regarding the mechanism of reverse tran-
scription of retroviral RNA; the exact role of the p32 endonu-
clease in viral replication as well as mechanisms for the other 
pol gene functions are as yet unknown. 
Historically, mutants have been used extensively to study 
retroviral gene function. Many pol mutants have been isolated 
and have been at least partially characterized [for a review, 
see 84]. Since molecular cloning and rapid DNA sequencing 
techniques enable investigators to determine the nature of the 
defects more precisely, re-examination of pol mutants should 
result in new insights in understanding the function of the pol 
gene product. 
In this study, I present characterization of the pol de-
fect in BH-RSV alpha, a mutant with a stable pol" phenotype. 
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The results indicate that the defect appears to affect process-
ing and/or packaging of the pol gene product. This mutant 
should therefore prove useful in further studies of these two 
pathways. 
Transfection of viral DNA proved to be an invaluable assay 
for mapping the lesion. Since the original observation that 
viral DNA is transforming [55], the transfection assay has been 
used extensively to study retrovirus genetics and transforma-
tion. In this study, the requirement of viral replication for 
transformation of transfected CEF [22] was exploited to develop 
a bioassay for pol gene function. In vitro recombination tech-
niques similar to those described in recent reports [98,116], 
were used to succesfully localize the pol defect to a discrete 
fragment within the pol gene. 
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RESULTS 
BH-RSV alpha-Infected Cells: Protein Studies 
Antiserum controls. The BH-RSV alpha pol-related proteins 
synthesized either in the infected cells or packaged into 
virion particles were examined by immunoprecipitation followed 
by polyacrylamide gel electrophoresis. Antisera directed 
against whole virions or specific for reverse transcriptase 
were used; the characteristics of these antisera were deter-
mined by immunoprecipitation of proteins from RAV-2 virions and 
RAV-2-infected cultures. As shown in Fig. 3.1, panel A (lanes 
2-3), reverse transcriptase antiserum (anti-pol serum) precipi-
tated the reverse transcriptase subunits, p95p and p63p , 
from virion particles. The serum also precipitated some viral 
structural proteins but most of this activity was removed by 
absorption of the serum with disrupted virus (compare lanes 2 
and 3 ). 
The anti-pol serum precipitated the gag-pol precursor 
Prl80 from infected cells (lanes 5 and 6); p95P° and p63P° 
were not detected in infected cells. The 67K protein which was 
precipitated with the absorbed anti-pol serum was a cellular 
contaminant as demonstrated in panel B. 
Antiserum against whole virions (anti-virion serum) pre-
cipitated the gag-pol precursor Prl80 from infected cells (lane 
4); the other viral proteins, gPr92env, Pr76gag, p27gag, 
pl9gag, pl5/pl2g g were precipitated with this antiserum as 
well. 
Figure 3.1̂ . Characteristics of anti-pol and anti-virion sera. 
(A) Lanes 1 through 3 contain equal amounts of S-methionine 
labeled RAV-2 virions which were purified as described in Ma-
terials and Methods. .Lanes 4 through 6 contain immunoprecipi-
tates of lysates of S-methionine labeled RAV-2 infected 
cells. Lane 1, no immunoprecipitation; lanes 2 and 5, immu-
noprecipitation with anti-pol serum; lanes 3 and 6, immunopre-
cipitation with absorbed anti-pol serum; lane 4, immunoprecipi 
tation with anti-virion serum. (B) Uninfected (CEF) or RAV-2-
infected (RAV-2) cells were labeled with S-methionine and 
cell lysates were prepared. Immunoprecipitation was performed 
with anti-virion serum (V) or anti-pol serum (P). Bands 
correpsonding to viral proteins are indentified on the right. 
Electrophoresis was performed on 7.5% SDS-polyacrylamide gels. 
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Viral proteins in BH-RSV alpha-infected cells. "Non-
Producer" (NP) clones of CEF infected with BH-RSV alpha, free 
of helper virus, were isolated and the viral proteins were ex-
amined. Figure 3.2 shows the results of immunoprecipitation of 
viral proteins from extracts of BH-RSV alpha-infected cells us-
ing the anti-virion or anti-pol antiserum. Immunoprecipitates 
from RAV-2-infected cells run in parallel lanes are shown as 
controls. In all four NP clones, a band which co-migrates with 
the RAV-2 Prl80 was precipitated by both anti-virion and anti-
pol serum. These results clearly indicate that BH-RSV alpha, 
although defective in polymerase, can direct the synthesis of a 
normal-sized gag-pol polyprotein precursor. 
Immunoprecipitation with anti-virion serum (lanes marked 
"V") demonstrated the presence of the gag protein products in 
BH-RSV alpha-infected cells. As expected from the defective-
ness of BH-RSV alpha in env, the env protein gPr92 was not 
detectable in the cell extracts from all the NP clones. 
Figure 2^-2' BH-RSV alpha proteins in infected cells. Cell 
lysates were prepared from cultures which had been labled with 
S-methionine. R-2, RAV-2 infected mass culture; 1 through 4, 
independent BH-RSV alpha NP clones. Immunoprecipitation was 
performed with either anti-virion serum (V) or absorbed anti-
pol serum (P). The positions of molecular weight markers run 
in parallel lanes of the gels are shown in the center. The 
bands corresponding to Pr76 and Prl80 are identified. Electro-
phoresis was performed on 5-15% SDS-polyacrylamide gradient 
gels. 
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Proteins in BH-RSV alpha virions As shown in Fig. 3.1, the 
mature reverse transcriptase subunits were not detected in im-
munoprecipitates of RAV-2-infeeted cells; however p95 and p63 
were readily detectable in immunoprecipitates of purified RAV-2 
virion particles. Figure 3.3 shows the results of immunopre-
cipitation of BH-RSV alpha virion particles. No polymerase-
related proteins were detected in the virions released from at 
least 3 NP clones (panel A). In each of these 3 clones there 
was sufficient production of viral particles, as evidenced by 
the precipitation of gag proteins upon reprecipitatation with 
anti-virion serum (panel B), to rule out lack of virus produc-
tion as the cause of the negative result. This confirms ear-
lier results [44,101] in which a radioimmunoassay failed to 
detect any pol related products in BH-RSV alpha virions. 
In conclusion, the pol-negative mutant, BH-RSV alpha, 
directs the synthesis of a full sized Prl80 gag-pol precursor 
molecule. However, this molecule is apparently not cleaved 
into the mature products p95 and p63 since BH-RSV alpha virion 
particles do not contain any polymerase-related proteins. 
Figureg3.3 BH-RSV alpha proteins in purified virions. Puri-
fied S-methionine labeled virion particles were immunoprecip-
itated with absorbed anti-pol serum (panel A). The material 
which did not precipitate was reprecipitated with anti-virion 
serum (panel B). The lane headings are the same as in Fig. 
3.2. The positions of molecular weight markers run in parallel 
lanes of the gels are shown in the center. The bands 
corresponding to reverse transcriptase are identified. Elec-
trophoresis was performed on 10% (panel A) or 5-15% (panel B) 
SDS-polyacrylamide gels. 
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Processing of Prl80. The processing pathway in the pro-
duction of p95 and p63 from Prl80 is not well understood. Cul-
tures of RAV-2-infeeted cells were used to determine whether 
processing of Prl80 occurs within virion particles. Cultures 
35 
were labeled with S-methionine for a short period, followed 
by a "chase" with unlabeled medium, according to the protocol 
described by Oppermann [100]. Culture fluid was harvested and 
35 
S-labeled virion particles were purified, immunoprecipitated 
with anti-pol serum, and examined by SDS polyacryalmide gel 
electrophoresis. The results (Figure 3.4) show that at early 
time points, (30-60 min. of chase), Prl80g g ™ was the major 
£ol-related protein in virion particles. Within the second 
hour of the chase, the precursor form, Prl80, was processed 
into the mature form, p95 and p63. After 3 hours of chase, p95 
and p63 were the major pol-related products in the virions. 
These data support the hypothesis that processing of Prl80 oc-
curs exclusively in the virion particles; a similar hypothesis 
has been proposed for the processing of the gag-pol precursor 
of murine retroviruses [149]. 
Figure 2*4^ Appearance of pol-related polypeptides in virions 
following pulse-labeling of RAV-2 infected cells. A 65 mm dish 
of RAV-2 infected CEF which had been starved of methionine for 
one hour was labeled with lmCi of S-methionine for 30 min. 
The medium was withdrawn, cells were washed, and fresh medium 
containing an excess of unlabeled methionine was added. The 
medium was withdrawn and replaced with fresh medium at the in-
dicated time points. Virus was purified from each portion of 
medium and immunoprecipitated with anti-pol serum. (0*), the 
virus collected after the labeling period; (15'), the virus 
collected between 0-15 min after removal of the label; (30'), 
30-60 min.; (2h), 1-2 hr; (3h), 2-3 hr; (6h), 3-6 hr; (12h) 6-
12 hr. Electrophoresis was performed on a 7.5% SDS-
polyacrylamide gel. 
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However when purified virion particles from culture super-
natants were examined from cultures which were continuously la-
beled for various time periods (1 to 6 hr.), Prl80 was not 
detectable in the virion particles (data not shown). Although 
the labeling conditions in the two experiments differed and 
this may account for the discrepancy (1 mCi was used in the ex-
periment in which Prl80 was detected in the virions and 300 uCi 
was used in the experiment in which it was not detected), 
further work must be done to elucidate the mechanism of Prl80 
processing. 
Characterization of BH-RSV alpha on the DNA Level 
Since the BH-RSV alpha viral genome directs the synthesis 
of an apparently normal Prl80 precursor and since no obvious 
defects in the structure of the BH-RSV alpha pol gene were 
detected by restriction enzyme mapping, I sought to determine 
whether the defect actually mapped in the pol gene. The bio-
logical activity of the BH-RSV alpha pol gene was tested in a 
transfection assay. As a control, the activity of the BH-RSV 
beta pol gene was examined in a similar manner. 
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TRANSFECTION ASSAY DESIGN 












Figure _3»J3» Transfection assay design. pSR-REP and pSR-XD are 
derived from pSRA, a pBR322 molecular clone containing the en-
tire genome of SR-RSV [24]. After Sail digestion and ligation 
of the fragments of the two clones, the ligated mixture is 
transfected onto CEF (see Materials and Methods). One of the 
ligation products will be a structure equivalent to an SR-RSV 
provirus. Sa, position of Sail sites on the plasmids. 
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The transfection assay of CEF as designed by Cross and 
Hanafusa [24] was used (Figure 3.5). Two SR-RSV molecular 
clones, pSR-REP and pSR-XD, are ligated prior to transfection 
to generate an intact SR-RSV proviral genome. pSR-REP contains 
the SR-RSV 5* LTR, gag and pol genes, and the gp85-portion of 
the env gene; pSR-XD contains the SR-RSV gp37-portion of env, 
the src gene, and the 3' LTR. Neither plasmid alone can cause 
transformation of CEF since viral replication is required for 
stable transformation of transfected CEF [22]. 
Construction of SR-RSV/BH-RSV chimeras. Because of the 
requirement of viral replication for stable transformation, it 
was possible to use morphological transformation as a marker 
for assaying the biological activity of pol. Construction of 
in vitro recombinants between the pSR-REP clone and pBH-alpha 
or beta clones resulted in generation of viral DNA which con-
tained all of its genes and regulatory sequences from SR-RSV 
except for a pol gene which was derived from BH-RSV alpha or 
beta. The strategy for construction of these recombinants is 
shown in Figure 3.6. The EcoRI-Kpnl fragment contained the 
gag-pol junction and more than 90% of the pol gene (the portion 
of the pol gene between the Kpnl site and the termination codon 
had already been partially sequenced and was found to be essen-
tially identical in the alpha and beta strains (Fig. 2.5)). 
E Bo 
Figure 2*£* Construction of SR-RSV/BH-RSV chimeric clones. 
(A) Structure of molecular clones which were used to derive the 
chimeric constructions [24, and Chapter 2, this thesis]. (B) 
Products of EcoRI and Kpnl digestions described in the text. 
(C) Structures of resulting recombinants. The positions of 
relevant restriction enzyme cleavage sites are shown. For sim-
plicity, in (C) and in Figs. 3.7 and 3.8, the EcoRI and Kpnl 
sites are shown at the 5' and 3* borders of pol. E, EcoRI; K, 
Kpnl; Xh, Xhol; Ba, BamHI. 
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The EcoRI-Kpnl pol-containing restriction fragment was ex-
cised from pBH-alpha or pBH-beta DNA by complete digestion with 
Kjonl and EcoRI. The excised fragment was ligated to pSR-REP 
DNA which had been linearized by complete digestion with Kpnl 
and then had the pol-containing EcoRI-Kpnl fragment removed by 
partial digestion with EcoRI. DNA of the in vitro-constructed 
pol recombinants was amplified by transformation of E. Coli; 
colonies were then screened for plasmids of the desired con-
struction. Since both BH-RSV strains contained an Xhol site in 
pol which was not present in SR-RSV, and since BH-RSV beta con-
tained an extra BamHI site in pol which was not present in BH-
RSV alpha or SR-RSV (Fig. 2.3), these two enzymes were used to 
determine the origin of the EcoRI-Kpnl pol fragment in the 
recombinants. The resulting recombinants, pSR-pol-alpha and 
pSR-pol-beta, had the constructions shown in Fig. 3.6C. 
Mapping the defect to the pol coding sequences. DNA from 
pSR-REP, or the recombinants pSR-pol-alpha or pSR-pol-beta, was 
ligated to pSR-XD DNA and transfected onto chicken embryo fi-
broblasts as shown schematically in Figure 3.5. Replacement of 
the SR-RSV pol gene with the BH-RSV alpha pol gene abolished 
focus-forming ability, while replacement of the SR-RSV pol gene 
with that of BH-RSV beta did not affect focus-forming ability 
(Table I). Therefore, the defect which is responsible for the 
lack of acitivity in the transfection assay and presumably, for 
the lack of reverse transcriptase enzyme in BH-RSV alpha virion 
particles, maps within the EcoRI-Kpnl fragment of BH-RSV alpha. 
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T R A N S F E C T I O N A S S A Y 
V i r a l D N A 
5' portion 3' portion 






Total transformation after 8 days 
No foci after 8 days 
Total transformation after 5 days 
No foci after 8 days 
Table I. Transfection of CEF with viral DNAs. In each experi-
ment , 4 ug of each DNA species was used for transfection of 
four 65 mm dishes of CEF, according to the protocol outlined in 
Fig. 3.5. Cultures were transfered and overlaid with agar as 
described in the Materials and Methods and monitored for the 
appearance of foci. 
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Construction of recombinants within the pol gene. The 
Xbal and Bglll cleavage sites within the EcoRI-Kpnl fragment, 
divide the 2.7 kb fragment into three fragments of 1.07, 0.86, 
and 0.76 kb. Figure 3.7 shows the strategy used for construct-
ing recombinants which would enable the pol defect to be mapped 
to one of these three fragments. 
pSR-pol-alpha and pSR-pol-beta were used as parentals. 
The DNAs were linearized by complete digestion with the 
single-cut enzyme SstI and partial digest conditions were used 
to generate Sstl-Xbal or Sstl-Bglll fragments cut in pol (Fig. 
3.7B). The Sstl-Xbal and Sstl-Bglll "vector" (larger) and "in-
sert" (smaller) fragments from pSR-pol-alpha and pSR-pol-beta 
were each cut from an agarose gel and purified separately. To 
remove undigested or nicked circular plasmid (i.e., parental) 
DNA which may comigrate with the vector fragments, purified 
vector fragments were further digested with Hpal. Hpal cleaves 
parental DNA at a single site which maps within the fragment 
which is not present in the two vectors (Fig. 2.3). 
For both the Sstl-Xbal and Sstl-Bglll digestion products, 
the pSR-pol-alpha vector was ligated to the pSR-pol-beta insert 
and the pSR-pol-beta vector was ligated to the pSR-pol-alpha 
insert, resulting in the construction of the four pol recom-
binants illustrated in Figure 3.7C. BamHI, which differen-
tiates the BH-RSV alpha- and beta-derived inserts, was used to 
verify the constructions. 
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POL gene _ _|_ 
activity 
SstI /Xbal digest 
OR 
Sst I /Bg III digest 
Figure 3.»]7. Construction of recombinants within pol. (A) 
Structure of molecular clones which were used to derive the 
recombinants. Activity of the pol gene was based on data in 
Table I. (B) Products of SstI-Xbal or Sstl-Bglll double diges-
tions described in the text. (c"5 Structures of resulting 
recombinants. In (A) and (B) the positions of relevant res-
triction enzyme sites are shown. Ss, SstI; Xb, Xbal; Bg, Bglll; 
E, EcoRI; K, Kpnl. 
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Localization of the defect to a defined region of pol 
c[ene. The four recombinants shown in Fig. 3.7 were used in the 
DNA transfection assay to unambiguously map the pol defect to 
either the 1.07 kb EcoRI-Xbal ("P") fragment, the 0.86 kb 
Xbal-Bglll ("0") fragment, or the 0.76 kb Bglll-Kpnl ("L") 
fragment. The gag-pol junction maps in the "P" region; the 
site at which p95P° is cleaved into p63p and p32 is thought 
to map in the "0" region. As shown in Figure 3.8, given that 
the alpha-derived pol fragment is negative and the beta-derived 
fragment is positive in the transfection assay, the four recom-
binants which were constructed would yield a unique array of 
results depending on whether the mutation mapped in "P", "0", 
or "L". (Other unique patterns of results which would be ex-
pected if more than one mutation existed are not shown in the 
figure.) 
When the four recombinants were tested in the transfection 
assay, successful transformation of CEF correlated with a 
beta-derived "0" region only. Conversely, inability to produce 
foci on CEF, correlated with an alpha-derived "0" region ir-
respective of the origin of the "P" or "L" fragments (Fig. 
3.8). 
Thus, the defect in BH-RSV alpha which results in a Prl80 
protein which does not seem to be processed is due to a muta-
tion in the coding sequence of its pol gene. The mutation maps 
to an 859 bp Xbal-Bglll fragment in the central portion of the 
gene. Sequencing of this region is currently in progress. 
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TRANSFECTION OF POL RECOMBINANTS 
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Difference between the pol gene of SR-RSV and Bryan RSV 
beta. Both SR-RSV and BH-RSV beta have wild-type pol genes 
which would be expected to be equally active in a transfection 
assay. It appeared that pSR-pol-beta, the construct in which 
the pol gene of SR-RSV was replaced with that of BH-RSV beta, 
was more active in the transfection assay than the parental 
pSR-REP (Table I). pSR-pol-beta consistently (more than 5 in-
dependent experiments) caused rapid and complete transformation 
of the cultures in 5 days, while under the same conditions, 
cells transfected with pSR-REP did not begin to show discern-
able foci until day 6, and the plates did not become completely 
transformed until (at least) day 7. 
This observation was confirmed by the measurement of the 
kinetics of production of infectious viral particles by pSR-
REP- and pSR-pol-beta-transfected cultures. Culture superna-
tants collected daily, beginning 4 days post-transfection, were 
used to determine the titer of infectious viral particles. As 
can be seen in Figure 3.9, the pSR-pol-beta-transfected cul-
tures consistently contained 10-100 fold more infectious parti-
cles than the pSR-REP cultures; even the maximum titer attained 
by the two cultures differed by at least a factor of 10. 
Replacement of the 2.7 kb EcoRI-Kpnl pol fragment of SR-
RSV with that of BH-RSV beta resulted in an enhancement of 
viral replication. Many functions have been attributed to the 
retrovirus pol gene, and we do not know which function in BH-
RSV contributes to such a dramatic stimulation of infectous 
virus. 
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Virus production after transfection with 
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Days after transfection 
Figure 3̂ *9̂  Titer of infectious virus in culture fluid of 
cells transfected with viral DNA. Sail-cut pSR-REP (filled 
circles) or pSR-pol-beta (open circles) DNA was ligated to 
pSR-XD DNA and ligated DNA was transfected onto CEF. Beginning 
four days after transfection, culture fluid was collected daily 
and clarified fluid was used to determine the number of focus 
forming units (ffu)/ml. For pSR-REP-transfected cultures, the 
titer on day 4 was below detection limits of the assay (100 
ffu/ml). 
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DISCUSSION 
Polymerase Defect in BH-RSV alpha 
Restriction enzyme mapping studies using a large number of 
enzymes found the structure of the BH-RSV alpha pol gene to be 
almost indistinguishable from that of wild type pol genes 
(Figs. 2.2 and 2.3). Protein studies indicated that although a 
full length gag-pol precursor was synthesized, neither the ma-
ture processed pol products nor any other polymerase related 
proteins were detected in BH-RSV alpha virions (Figs. 3.2 and 
3.3). In this respect, the pol defect in BH-RSV alpha seems to 
be quite different than that of other non-conditional pol mu-
tants which have been examined biochemically. 
The pol" phenotypes in mutants Q-PH9 and SE52d, and in the 
provirus ev3 are due to deletions in the respective pol genes; 
all three synthesize a truncated form of Prl80 (P140, P125, and 
P120 respectively) in infected cells and, with the exception of 
ev3 which does not produce viral particles, they do not produce 
reverse transcriptase protein in their viral particles 
[33,34,85,90]. 
There does not appear to be a deletion or major sequence 
rearrangement affecting the pol sequences of the ev-1 provirus 
[60,125], yet like BH-RSV alpha, ev-1 (under conditions where 
it is expressed) virion particles do not contain reverse 
transcriptase-related proteins [21]. However, immunoprecipita-
tion of cell lysates showed that ev-1-expressing cells do not 
synthesize any intracellular gag-pol product [21]. The cause 
of the ev-1 pol defect has not been determined. 
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The AMV genome directs the synthesis of a full size 
Prl80 *^ protein, yet virion particles contain no reverse 
transcriptase-related proteins [32]. Although this seems to be 
phenotypically identical to the BH-RSV alpha pol defect, the 
cause of the AMV defect is now understood. Recent DNA sequence 
data has demonstrated that the pol defect in AMV is due to 
insertion of the myb gene into the 3* end of pol (between the 
Kpnl site and the termination codon) [78,110]. As a result, 
the last 36 amino acids of AMV pol are probably derived from 
c-myb [78]. However, DNA sequencing of BH-RSV alpha demon-
strated that this portion of the pol gene was not significantly 
different than the wild type pol gene (Fig. 2.5). 
Other models to explain the BH-RSV alpha pol defect must 
therefore be considered: 
1) Defect in splicing pol mRNA: The avian gag and pol 
gene products are encoded on different reading frames of viral 
RNA [117] and a splicing event is presumably required to remove 
the gag translation terminator and shift the reading frame. 
Suppression of the gag terminator and continued translation in 
the gag reading frame has been shown to result in a read-
through protein of 80 kD [147]. A shift to the incorrect read-
ing frame would presumably result in an even smaller read-
through protein [based on 117]. Therefore, the presence of a 
full size BH-RSV alpha gag-pol precursor protein, containing 
pol antigenic determinants, argues against a defect in the 
splicing event. However, a splicing defect may explain the na-
ture of the ev-1 defect (see above) [21]. 
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2) Lesion outside of pol: Consistent with the protein 
and restriction mapping data is the hypothesis that the defect 
in BH-RSV alpha affects its reverse transcriptase protein but 
does not map within pol. A possible candidate for such a de-
fect would be the protease responsible for processing of Prl80. 
gag 
pl5 protease has been implicated in virus maturation 
[29,143,144]. In vitro, pl5 cleaves Prl80 non-specifically 
[34,94], however, this does not rule out the possibility of a 
role for pl5-mediated processing of Prl80 in vivo. In fact, 
pl5 has been shown to cleave p95p° quite specifically into 
p63P and a 32 kD protein [94]. Assuming that processing of 
Prl80 occurs prior to packaging, BH-RSV may be a processing mu-
tant due to a defective protease (pl5 or another, as yet 
unidentified, viral activity involved in processing) or due to 
an alteration of a cleavage site(s). 
3) Defect in packaging: Preliminary evidence presented 
in Fig. 3.3 indicates that unprocessed Prl80 may be the moeity 
which is packaged into the virions. In that case, a processing 
defect cannot account for the lack of detectable reverse 
transcriptase-related proteins in virion particles. Even if 
BH-RSV alpha Prl80 was not cleaved or cleaved only partially, I 
would have expected to detect the accumulation of uncleaved 
Prl80 or one of its processing intermediates in virion parti-
cles . 
If packaging of Prl80 is indeed a prerequisite for pro-
cessing, BH-RSV alpha may be a packaging mutant with a lesion 
in pol which renders the Prl80 protein unpackageable. Alterna-
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tively, if an interaction between the pol proteins and the 
virion core proteins or the viral RNA is required for packaging 
of the enzyme, a defect in gag or in a non-coding region of 
viral RNA could produce the observed phenotype. Although there 
is no evidence that such interactions, are required, it is 
known that the pol gene product binds tRNAtrp [102] and seems 
to be responsible for selecting a specific cellular tRNA pool 
for packaging [104,113], 
4) Artifact of molecular cloning: The protein analysis 
of BH-RSV alpha was performed on many independent clones of NP 
cells (Figs 3.2, 3.3, and data not shown), whereas the restric-
tion mapping was performed on one molecular clone. The possi-
bility that the pBH-alpha clone was not representative of the 
BH-RSV alpha genome also had to be considered. 
The transfection assay resolved many of these points. The 
biological activity of molecularly cloned DNA fragments used in 
this study was confirmed. The reverse transcriptase defect in 
BH-RSV alpha was localized to a specific fragment within the 
BH-RSV alpha pol gene, effectively eliminating the possibility 
that the lesion mapped outside of pol or in the gag-pol junc-
tion. Until the DNA sequence of the defective region is avail-
able, the exact nature of the pol defect is still a matter for 
speculation. 
The cleavage site used in processing p95 into p63 and p32 
is thought to map within the defective region [D. Grandgenett, 
personal communication]. While such a defect would certainly 
affect processing of reverse transcriptase, whether it could 
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also affect packaging of pol products is not clear. However, 
if the defect causes a major alteration in the protein se-
quence, a conformational change affecting Prl80 (or p95) may 
prevent proper packaging. 
The pol defect in AMV may also be related to packaging. 
It does not seem likely that the proposed carboxy terminal sub-
stitution in the AMV Prl80 protein affects any of the cleavage 
sites used in processing of this protein. Since pol (or pol-
related) proteins are not detected in viral particles, the 
resulting alteration in protein structure may prevent proper 
packaging. Further studies on the fate of the BH-RSV and AMV 
Prl80 proteins should be useful in establishing the relation-
ship between processing and packaging. 
Proposed mechanisms for the generation of the BH-RSV alpha 
defect must account for both the frequency of its occurance 
(5-10%) and its low rate of spontaneous reversion [46]. A 
point mutation is unlikely to be stable. An in-frame deletion 
would be consistent with the evidence presented, provided the 
deletion was small enough to be undetectable by the restriction 
enzyme mapping analysis. Another possibility is that the BH-
RSV alpha pol defect is generated by recombination. Almost all 
the ev proviruses contain some pol sequences [53]. Since ear-
lier studies found the frequency of generation of the BH-RSV 
alpha defect to be independent of the gs or chf phenotype of 
the embryo [112], a recombination model would have to assume 
» 
that there is a defective portion of pol which is conserved 
among most of the ev's, or would have to assume recombination 
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mvolved the commonly found provirus ev-1. It is possible that 
ev-1 contains an internal defect in pol, in addition to the 
proposed splicing defect (see above). 
Processing of Prl80 
Whereas mature reverse transcriptase protein and enzymatic 
activity are readily detectable in virion particles, many work-
ers have reported the inability to detect the reverse tran-
scriptase subunits or reverse transcriptase enzymatic activity 
in retrovirus-infected cells [34,51,100,149]. It is therefore 
believed that cleavage of Prl80 and formation of mature pol 
products occurs very close to the time of release of virion 
particles from the infected cells. However, whether cleavage 
occurs before, after, or during the budding process has not 
been resolved. Although there is general agreement regarding 
the absence of detectable amounts of p95 and p63 in infected 
cells, the presence of Prl80 in mature virion particles is the 
subject of conflicting reports. 
In the report in which the avian Prl80g g ^ was initial-
ly described, Oppermann et al [100] note the presence of high 
molecular weight bands in polyacrylamide gels containing pro-
teins from purified virion particles and suggest that one of 
these bands represents Prl80. This high molecular weight pro-
tein comigrates (on their gel system, i.e., 11% polyacrylamide) 
with Prl80 found in infected cells and appears in pulse-chase 
experiments only in virion particles harvested at early time 
points after removal of the radioisotope. However immune pre-
cipitation was not used to firmly establish the identity of 
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this band as the pol precursor. 
Moelling et al [94] report the presence of Prl80 in 
Coomassie blue-stained polyacrylamide gels of disrupted virion 
particles. Virion "Prl80" was identified by comigration with 
cellular Prl80; immune precipitation was not used. 
Eisenman et al [34] report the absence of Prl80 in ra-
dioactively labeled virion particles which were immunoprecipi-
tated with anti-reverse transcriptase serum. Virions were 
purified from cultures which had been labeled continuously for 
1-6 hr. These workers also report (although the data is not 
shown) that Prl80 could not be immunoprecipitated from virions 
purified from cultures which they had labeled according to the 
pulse-chase protocol described by Oppermann et al. 
In an attempt to clarify this conflict, I repeated the ex-
periments of Oppermann et al and Eisenman et al. In order to 
verify the identity of high molecular weight bands which may 
appear in the virions, immunoprecipitation with anti-pol serum 
was used in repeating Oppermann's experiment. In our experi-
ments in which parallel cultures of infected cells were used, 
the contradictory reports of both sets of workers were con-
firmed; Prl80 was clearly identified in virions in the pulse-
chase experiment and was undetectable in the continuous label-
ing experiment (Fig. 3.4, and data not shown). These results 
must therefore be regarded as preliminary and resolution of the 
question of packaging of Prl80 will require further investiga-
tion. 
Temperature sensitive packaging mutants Mo-MuLV ts3 [150] 
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and Ra-MuLV ts24 [131] were used to study the maturation of mu-
rine retroviruses. These studies [149] suggest that the se-
quence of events in late stages of assembly is: encapsidation 
of uncleaved PrlSO9^"^1 followed by cleavage into reverse 
transcriptase in newly formed virions. Processing of Prl80 ap-
pears to occur rapidly, within 40 min of release of the virion 
particle. These workers suggest that activation of reverse 
transcriptase in virion particles may reflect a general mechan-
ism whereby premature reverse transcription of viral RNA is 
prevented from occurring within the cell. For this reason, ac-
tivation of reverse transcriptase (by cleavage) within virion 
particles would be advantageous to avian retroviruses as well. 
Enhanced viral production by the pol gene of BH-RSV beta 
It is not clear which function of the BH-RSV beta pol gene 
product accounts for the increased production of infectious 
virus by cells which were transfected by pSR-pol-beta as com-
pared to pSR-REP (Fig. 3.9). Possibly, the rate of one of the 
enzymatic activities of the reverse transcriptase protein is 
increased. Alternatively, assuming that packaging of reverse 
transcriptase (either as Prl80 or as p95/p63) or selection of 
tRNA ^ and/or binding of it to viral RNA are somewhat ineffi-
cient processes, the BH-RSV pol gene product may have a struc-
tural alteration which increases its efficiency. In such a 
model, the ratio of infectious to physical viral particles 
would be higher in viruses containing the BH-RSV pol gene. 
Further work will have to be done to understand this puz-
zling phenomenon. The virus harvested from the supernatants of 
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pSR-REP and pSR-pol-beta transfected cultures should be exam-
ined to determine the kinetics of production of infectious par-
ticles early after infection. Also, to rule out the possibili-
ty that the pol gene of pSR-REP may have incurred a defect dur-
ing molecular cloning, SR-RSV virus should be included for com-
parison in future experiments. It would also be interesting to 
examine the purified enzyme encoded by BH-RSV beta pol. If the 
efficiency of synthesis or fidelty of the transcript is sub-
stantially increased in comparison to other viral polymerases, 
this enzyme may be valuable for in vitro uses of reverse tran-
scriptase (i.e., cDNA cloning). 
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